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INTRODUCTION
Intra-oral devices in the treatment of snoring and related problems such as 
obstructive sleep apnoea have only been used for the last 10-15 years. 
Among the first appliances used in the treatment of snoring and obstructive 
sleep apnoea (OS A) were modified functional orthodontic appliances 
which is not surprising given that such appliances are used to induce 
changes in skeletal relationships.
There have been a variety of designs, the most common being those which 
reposition the mandible in an open, protrusive position. However, 
appliances have become more sophisticated and complex in design and 
therefore more expensive. The development of an appliance that could be 
constructed simply and economically and yet still be effective in managing 
snoring was necessary.
Most studies of intra-oral devices had used strict entry requirements in 
terms of oral health and number of teeth. This present study aimed to treat 
a wide representation of patients referred from a sleep clinic. Patients 
were only excluded if they had no natural teeth remaining. This study 
aimed to use a simple method and inexpensive materials. Previous studies 
had shown that airway patency was improved with an oral device by using 
a variety of evaluation methods, including cephalometric analysis, 
magnetic resonance imaging, fluoroscopy, computerised tomography and 
polysomnography.
This study chose to use simple success criteria, questionnaires to patients 
and their partners as the method of evaluation. In effect this was a 
treatment of both the patient and partner as snoring more often disturbs the 
partner more than those who snore. However, patients were also 
evaluated by a home sleep study before and after treatment with the 
appliance to objectively measure the effect of the appliance on sleep 
variables.
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AIMS AND OBJECTIVES
The aim of the project was to investigate the acceptability and effectiveness 
of a dental device of simple design and construction in the treatment of 
snoring and obstructive sleep apnoea in patients with varying backgrounds 
and dental states.
Specific aims were:
• to assess the effect of a simple mandibular advancement appliance on 
snoring
• to assess the effect on sleep quality of patients and partners
• to assess the effect on daytime sleepiness
• to assess the longevity of the appliance
• to assess the effect of the mandibular advancement device on sleep study 
parameters
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CHAPTER 1 
REVIEW OF THE LITERATURE 
1.1 Introduction
The Oxford English Dictionary (1998) defines snoring as “ To make harsh 
or noisy sounds in sleep through the open mouth and nose”. Snoring is 
often regarded as merely a social problem that disturbs others rather than 
the snorer. However, snoring affects breathing during sleep and is also a 
principle symptom of the potentially serious condition of obstructive sleep 
apnoea (OSA). Obstructive sleep apnoea syndrome is one of a number of a 
problems referred to as Sleep Breathing Disorders.
1.2 Apnoea
1.2.1 Definition
Sleep Apnoea may be defined as “transient attacks of failure of automatic 
control of respiration resulting in alveolar hypoventilation which becomes 
more pronounced during sleep” (Dorland Medical Dictionary, 1994) and 
comes from the Greek for “want of breath”. The sleep apnoea syndrome 
was first described by Gastaut et al (1966) as a disorder associated with 
repetitive cessation of breathing during sleep although Kryger (1983) and 
Lavie (1984) reported that references were made to sleep apnoea symptoms 
in medical and literary papers long before this time but misdiagnosis of 
patients with sleep apnoea and scepticism regarding sleepiness as a clinical 
sign appear to be the main reasons for the syndrome being overlooked.
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This may be why Whyte et al in 1989 reported that the sleep 
apnoea/hypopnoea syndrome was rare up to this time in Britain. Sleep 
apnoea may be divided into obstructive sleep apnoea or central sleep 
apnoea.
1.2.2 Obstructive Sleep Apuoea (OSA)
OSA may be defined as “sleep apnoea resulting from collapse or obstruction 
of the airway with the inhibition of muscle tone that occurs during REM 
sleep” (Dorland Medical Dictionary, 1994). People with OSA may have 
several hundred apnoeic episodes per night, each lasting 10 to 200 seconds 
(Knudson and Meyer, 1993). Obstructive sleep apnoea is the temporary 
cessation of breath through closure of the pharynx, although the diaphragm 
continues to function and there is a suggestion that there may be failure of 
the reflex protective mechanisms in the pharynx. There are receptors in the 
pharynx that detect falls in pressure that distort the airway and these 
receptors provoke protective increases in pharyngeal dilator tone. Snoring 
itself may also be one of the stimuli that activates the dilator reflex. 
Interruption of this reflex may occur through years of pharyngeal trauma 
from snoring, mucosal oedema or toxic agents such as cigarette smoke and 
alcohol.
1.2.3 Central Sleep Apnoea (CSA)
CSA occurs when the drive to breathe is abnormally reduced during sleep, 
leading to arousal, asphyxia and associated oxygen desaturation.
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CSA is characterised by simultaneous cessation of both airflow and 
respiratory effort. Most patients suffering from central apnoeas also have 
intermittent obstructive episodes but when more than 55% of events are 
central in nature, the apnoea is defined as central (Meyer and Knudson, 
1989).
1.2.4 Mixed Sleep Apnoea
This term is used when a combination of central and obstructive sleep 
apnoea occurs, where apnoeic episodes are accompanied by no respiratory 
effort initially but are followed by respiratory muscle movement and finally 
airflow.
1.2.5 Hypopnoea
Hypopnoea is defined as a decrease in inspiratory flow and chest movement, 
coupled with oxygen desaturation. An apnoea-hypopnoea index (AHI) is 
the number of episodes per night of 10 seconds or more. This is also called 
the Respiratory Disturbance Index (RDI). The sleep apnoea/hypopnoea 
syndrome is defined as the occurrence of at least 30 apnoeas plus 
hypopnoeas over a seven hour period of sleep together with specific 
symptoms (Cartwright and Samelson, 1982). However, Stradling (1994) 
defined sleep apnoea as “A sleep disruption syndrome, sufficient to cause 
symptoms, that is due to a respiratory problem engendered by sleep itself, 
but may be also due to problems of respiratory drive.”
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Apnoeic episodes cause the oxygen level in the blood to drop and carbon 
dioxide levels to rise. Blood pressure may rise and the heart slows. The 
elevated blood pressure may eventually remain elevated during the day as 
well.
1.2.6 Symptoms of Sleep Apnoea
Some complaints that might suggest sleep apnoea include the following:
Loud snoring, often interrupted by loud gasps and long pauses in breathing
Excessive daytime sleepiness
Need for frequent naps
Decrease in concentration
Loss of memory
Decreased ability to function at work
Irregular heartbeat during sleep
Frequent accidents
Irritability/short temper
Morning headaches
Changes in mood or behaviour
Anxiety or depression
Decreased libido
Impotence
Frequent wakening/need to urinate during sleep
Hypnogogic hallucinations occurring while awake, but very groggy
Sudden wakening with a sense of disorientation.
Obstructive sleep apnoea is generally categorised as mild, moderate or 
severe depending on the number of apnoeas with oxygen desaturation 
below a certain level (i.e., <90%, <80%, <70%): the amount of time below 
a specific level of oxygen saturation and sleep fragmentation that is 
affected by the number of arousals during sleep. In general, mild OSA is 
5-20 events per hour, moderate OSA is 20-50 events per hour and severe is 
over 50 events per hour.
The prevalence of sleep apnoea syndrome has been estimated at 4 percent 
of men and 2 percent of women in the middle-aged work force (Young et 
al, 1993).
The upper airway resistance syndrome (UARS) is partial collapse of the 
upper airway with increased resistance and arousal which leads to 
symptoms of OSA ( Clark et al, 1996,b).
1.3 SLEEP
As snoring and obstructive sleep apnoea occurs during sleep, it is 
appropriate to discuss sleep itself. Sleep is a normal, regular state of rest of 
an organism. In contrast to the waking state, sleep is characterised by 
relative inactivity of physiological functions (breathing, heartbeat, and 
blood pressure) and a relatively low response to external stimuli.
Brainwave patterns, recorded by electroencephalography (EEG), are used to 
define sleep because of their unvarying association with sleep behaviour.
1.3.1 Stages of Sleep
Dement and Kleitman (1957) described the different stages of sleep and 
produced criteria for scoring sleep stages based on eye movements, body 
motility and dreaming recorded during sleep. This followed the 
observation first noted by Loomis et al (1937) that sleep is not a steady state 
and that sleep stages follow an ordered pattern. Rechtschaffen and Kales 
(1968) produced a manual of standardised terminology, techniques and a 
scoring system for sleep stages in human subjects.
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These stages are classified as stages 1 to 4.
In the waking state the EEG of the brain waves is characterised by alpha 
waves of 8 to 12 Hz and low voltage activity of mixed frequency. With the 
onset of sleep the alpha activity disappears. Stage 1 is considered the 
lightest stage of sleep and is characterised by low voltage desynchronised 
activity and sometimes by regular low voltage activity of between 4 to 6 Hz. 
Stage 2 follows after a short period of time (minutes), with the EEG 
showing what are called sleep spindles (after their pattern shape) at 13 to 15 
Hz. Stage 3 shows the appearance of delta waves (high voltage activity 
with low waves, 0.2 to 2.5 Hz). In stage 4, these delta waves occupy the 
major part of the record (Rechstchaffen and Kales, 1968).
During the course of a night’s sleep (7-8 hours), these stages form a 
continuous cycle of 4 or 5 periods of change from stages 2, 3, and 4 to a 
stage similar to stage 1. Persons awakened at this similar stage report in 60 
to 90 per cent of cases that they have been dreaming. These periods at the 
end of stage 4 are characterised by stage 1 EEG patterns and by rapid eye 
movements (REM). These periods of sleep are also referred to as D- 
(desynchronised or dreaming) sleep with the remaining stages known as S- 
(synchronised) sleep. The D and S states are also known, respectively, as 
REM (rapid-eye-movement) and NREM (non-rapid-eye-movement; as 
paradoxical sleep and orthodox sleep; or active sleep and quiet sleep).
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The stages in normal adult sleep patterns are;
Stage 1 - 2 - 3 - 4 - 3 - 2  - REM (70 - 90 minutes after sleep onset) -2 - 3- 4 - 
3 -2 - REM.
It has been noted that not only does sleep lead to profound changes in 
breathing and its control, but problems with breathing lead to gross 
fragmentation of sleep (Stradling, 1994). Polysomnography is the term 
used to monitor a patient in a sleep laboratory and includes 
electroencephalogram (EEG), chin encephalogram (EMG), and eye 
movement. The determination of respiratory effort is achieved by 
recording chest wall movements, oral air flow by means of a thermistor 
probe clipped to the lip, nasal air flow with a thermistor clip attached to one 
of the nostrils and blood oxygen saturation by means of a ear oximeter 
(Guilleminault et al, 1978).
1.4 Snoring
Snoring is an inspiratory noise caused by vibration of the soft palate, uvula 
or posterior pillars of the fauces, associated with a narrowing of the airway 
(Seifert, 1980; Berry and Block, 1984; Wagner and Price, 1987; Hoffstein et 
al, 1988; Paskow, 1988; Schmidt-Nowara etal, 1991; George, 1993; 
Lugaresi and Partenen, 1994). Wild animals do not snore because they 
sleep on their stomachs or sides. Man alone has developed the alternative 
of sleeping on his back, aided by the development of a curved bed in ancient 
Egypt, headrests, pillows, and hammocks (Dille, 1987).
24
There is no generally accepted terminology to distinguish between different 
kinds of snores. However there are differences, both qualitative and 
quantitative, that may be associated with either nasal based or tongue based 
vibration. Nasal based snoring can occur with partial blocking of the nose 
which reduces the pressure in the throat whilst taking a breath, which in 
turn can result in the walls of the throat being sucked together. Tongue 
based snores occur when the tongue falls back in the throat, narrowing the 
airway. Snores that can be regarded as “conventional” are rhythmic noisy 
breaths that occur when a person is asleep. However, there are those very 
loud snores that follow the silence of a sleep apnoea. Snorers have been 
shown to snore more during slow wave sleep and REM sleep, whereas light 
snorers snored uniformly during all sleep stages (Hoffstein et al, 1991).
Snoring is also associated with sleep apnoea, where obstruction of the 
airway causes a temporary cessation of breathing.
1.4.1 Snoring as a Social Problem
Snoring is associated with a number of social and physical problems such as 
restless sleep and daytime sleepiness, cognitive dysfunction and abnormal 
cardiovascular excitation (Guilleminault et al, 1991). Snoring and sleepiness 
have long been considered with derision and humour. The term “Pickwickian” 
was used to describe patients who were obese and suffered with difficulty in 
breathing and snoring, after a character, Joe, the sleepy red-faced fat servant boy
in Charles Dickens’ novel The Posthumous Papers o f the Pickwick Club (1836). 
The loudest reported snoring in the Guinness Book o f Records (1998) is 93 
decibels, which is the equivalent to working in a noisy environment. The Health 
and Safety Executive of the Department of Employment recommends protection is 
used at a minimum noise level of 85dB in the workplace. Loud snoring disturbs 
the sleep of the spouse or partner and it is common for heavy snorers and their 
partners to sleep in separate bedrooms. Cartwright and Knight (1987) reported 
that marriages did not necessarily represent social support but rather appeared to 
be an added burden for sleep apneoic patients. In a study by Chourd et al (1986) 
24 out of 43 men had to sleep in a separate bedroom because of the disturbance 
caused by their snoring. However, after uvulopalatopharyngoplasty, a surgical 
procedure that removes part of the soft palate and uvula, 17 of the 24 men 
returned to sharing a bedroom with their wives.
1.4.2 Anatomical Factors Involved in Snoring
Snoring can be observed from any age but normally begins before the age of 
30. Physical conditions that can effect snoring are narrowing of the upper 
airway because of relaxation of the muscles of the tongue, pharynx, soft 
palate, and jaw; masses in the airway including tonsils, adenoids, cysts, 
larger amounts of fat in the obese; excessive length of the soft palate or of 
the uvula; or restricted nasal airflow as with septal deviations, colds, 
allergies, and sinus infections. Snoring is related to the morphology of the 
nasal and pharyngeal airway (Hoffstein et al, 1988).
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In addition, a study of the effects of mouth opening on upper airway 
collapsibility in normal sleeping subjects showed that this may contribute to 
the occurrence of sleep-related breathing abnormalities (Meurice et al, 
1996). Mouth opening is associated with an inferior movement of the 
mandible that decreases the pharyngeal diameter.
1.4.3 Prevalence of Snoring
In a large scale study carried out in Bologna, Italy, by Lugaresi et al (1980), 
24% of men (n = 2858) and 13% of women (n = 2855) were found to snore. 
A study in the U.K. by Norton and Dunn (1985) reported that 42 per cent of 
2629 people claimed to snore. Another large study was carried out in 
Finland by Koskenvuo et al (1987a) who reported that 9% of men ( n = 
3847) and 3.6% of women (n = 3664) in an age range of 40-69 years snored 
always or almost always.
Schimdt-Nowara et al (1990) in a survey of respiratory disease among 1222 
Hispanic-American adults, found a prevalence of regular loud snoring of 
27% in men and 15% in women. Snoring has been shown to increase with 
age up to 60-65 years, but decrease thereafter (Cirignotta et al, 1989). 
However, this may be as a result of mortality in the population sample, as 
the prevalence of snoring in the elderly is more than in any other group.
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It has been estimated that there are 40 million snorers in the USA in the 41 
to 64 years age group and that apnoea may affect 10 million (George,
1993). The British Snoring and Sleep Apnoea Association, formed in 
1991, reported that 3.5m Britons, including up to a quarter of all middle- 
aged males, snore regularly (Pigott,1996).
It is generally accepted that men snore more than women, probably as a 
result of fat distribution in the body (male - upper body, female - lower 
body), and that after the menopause the number of women snorers is 
similar to men (possibly because progesterone stimulates respiration).
In a U.K. telephone interview of 2894 women and 2078 men aged 15-100, 
40 % reported snoring regularly and 3.8% reported breathing pauses during 
sleep (Ohayon et al, 1997).
1.4.4 Classification of Snoring
There is no generally accepted index for snoring, although Lugaresi et al 
(1983) have proposed the following for classifying the different stages of 
the heavy snorers disease (HSD). Heavy snorers were divided into four 
groups:
1. subjects with heavy snoring presenting apnoeas sporadically or in short 
clusters;
2. subjects with heavy snoring alternated with prolonged sequences of 
obstructive apnoeas;
3. subjects with obstructive apnoeas lasting for almost the whole length of 
sleep;
4. subjects with typical obstructive breathing pattern and alveolar 
hypoventilation persisting during wakefulness.
The suggested four stages of HSD classification were:
Stage 0 (or preclinical) : heavy and habitual snoring with sporadic apnoeas 
confined to REM and stages 1-2 sleep;
Stage I  (or initial): almost continuous apnoeas during light and REM sleep; 
Stage I I  (or overt): apnoeas persisting for almost the whole length of 
sleep;
Stage 111  (or complicated): alveolar hypoventilation persisting during 
wakefulness.
A classification of daytime drowsiness was also proposed by means of the 
multiple sleep latency test as a standard measure of sleepiness (Carskadon 
et al, 1986). Sleep latency (SL) is the interval between the time when the 
individual tries to sleep and the time when electroencephalographic patterns 
of sleep first develop.
Group 0\ with a mean SL greater than or equal to 10 min, considered 
normal daytime alertness;
Group A: with a mean SL between 10 and 7 min, considered borderline 
sleepiness;
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Group B: with a mean SL of between 7 and 4 min, considered excessive or 
pathological sleepiness;
Group C: with a mean SL less than 4 min, considered severe sleepiness.
1.5 Questionnaires Used in Obstructive Sleep Apnoea
Questionnaires have been used previously in studies of obstructive sleep 
apnoea by Partinen et al (1988), Stradling and Crosby (1991) and George 
(1993), (see Appendix B). Questionnaires used to assess sleepiness 
include the Stanford Sleepiness Scale (a self-rating scale to quantify 
subjective changes in sleepiness for any time period of the day or night; 
Hoddes et al, 1973); the Multiple Sleep Latency Test (a standard 
measurement of sleepiness; Richardson et al, 1978), and the Epworth 
Sleepiness Scale, (eight questions related to how sleepy someone may 
become in normal situations, Johns 1991), (see Appendix B).
The Epworth Sleepiness Scale is widely used by physicians in sleep 
breathing disorders clinics where obstructive sleep apnoeas are suspected 
(Johns, 1994; Hardinge et al, 1995; Engleman et al, 1996).
1.6 Visual Analogue Scale
One of the most widely used non-verbal measurement techniques is the 
visual analogue scale (VAS). This consists of a line, (usually 10-cm) 
which can be horizontal or vertical and at each end is an anchor or 
maximum response.
Subjects place a mark on the line at an appropriate point between the two 
extremes. This technique has been widely used in medicine and has been 
shown to be a valid, reliable tool, particularly for measuring both clinical 
and experimental pain (Sriwatanakul et al, 1983; Duncan et al, 1989).
The primary disadvantage of a verbal descriptor is that the given word does 
not necessarily have the same meaning for each person. However, visual 
analogue scales indicate the extremes only as end points on the 10-cm line 
and subjects can easily rate the general magnitude of the stimulus in 
relationship to the line length without necessarily considering the meaning 
of the anchors, (Duncan et al, 1989). Sriwatanakul et al (1983) reported 
that horizontal lines were preferable to vertical lines in terms of accuracy, 
as the usage of vertical lines tends to produce greater variation.
1.7 Risk Factors for Snoring
1.7.1 Obesity
An important risk factor for heavy snoring is obesity. An indication of 
obesity is the body mass index (BMI) which is weight in kilograms divided 
by the square of the height in meters (kg/m2) (Khosla and Lowe, 1967). A 
body mass index of 20-25 kg/m is considered normal. Adults with a BMI 
over 27 kg/m2 may be considered obese.
Koskenvuo et al (1987b) found that habitual snoring occurred in 7% of men 
and 2.8% of women with a BMI below 27 kg/m2 and in 13.9% and 6.1% 
respectively of all those with a BMI above this level.
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It has been proposed that upper body obesity may be related to heavy 
snoring, and this would explain why men are affected more than women.
In a study by Katz et al (1990) neck size was reported to be a useful 
indicator of upper body obesity because of the distribution of fat deposits.
In a study by Cartwright (1984) of 30 male patients who were evaluated by 
all night polysomnography, 24 of the subjects had an apnoea index which 
was twice as high during the time spent sleeping on their back as it was 
when they slept on their side, but this difference was inversely related to 
obesity. Although the number of respiratory events per hour was highly 
correlated with obesity, the increase in severity when sleeping on their back 
was most striking in those close to normal weight.
The relationship between obesity and craniofacial structure in obstructive 
sleep apnoea was studied by Ferguson et al (1995). In three groups of 
patients it was found that those with a normal neck size were less obese and 
had more craniofacial abnormalities (such as a smaller mandible and 
maxilla and a more retrognathic mandible). Patients with intermediate 
neck size had both upper airway soft-tissue and craniofacial abnormalities. 
Patients with a large neck size were more obese with larger tongues and soft 
palates and an inferiorly placed hyoid; this group had fewer craniofacial 
abnormalities. However, there was no difference between airway size in 
the three groups.
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1.7.2 Smoking
Cigarette smoking has been shown to increase the risk of snoring (Bloom et 
al, 1988; Kauffman et al, 1989) and this is thought to be because of 
irritation and inflammation of the upper airway by cigarette smoke. The 
study by Bloom suggested that a higher prevalence of snoring occurs among 
those who smoked more cigarettes and that snoring prevalence remained 
high in smokers who had recently stopped, although this declined in ex­
smokers within four years of quitting.
1.7.3 Alcohol
Issa and Sullivan (1982) reported that alcohol exacerbated sleep induced 
breathing abnormalities, caused lowering of arterial blood oxygenation 
during sleep and caused OS A in some asymptomatic snorers. A study by 
Mitler et al (1988) found that respiratory events were significantly 
augmented by alcohol consumed by moderate social drinkers. Both of 
these studies found that alcohol increased snoring and produced apnoeas, 
particularly in the first two hours after ingestion, although the number of 
subjects in each study was small (7 and 6 respectively). However, the 
studies by Bloom et al, (1988) and Kauffman et al, (1989) which used 
much larger samples (2187 and 457 subjects), suggested that the time that 
alcohol was consumed before sleep was more important than the quantity 
consumed.
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1.7.4 Hostility
Koskenvuo et al (1987b) reported an association between hostility and 
habitual snoring exists, as daytime sleepiness leads to hostility.
1.8 Evaluation of airway size
A review (Shepherd et al, 1991) suggested that information on upper airway 
size could be obtained by a variety of methods which included direct or 
fibreoptic visualisation, cephalometric radiographs, fluoroscopy, acoustic 
reflection, computerised tomography, and magnetic resonance imaging. 
Narrowing of the upper airway was usually located in the velopharyngeal or 
retropalatal segment of the upper airway. Obesity with enlargement of soft 
tissue structures was considered the predominant mechanism leading to 
upper airway narrowing although abnormal craniofacial development, either 
genetic or developmental, also played a contributory role. Lowe (1993) 
used cephalometrics and computerised tomography and suggested that a 
high apnoea index (Al) was associated with a large tongue and soft palate 
volume, a retrognathic mandible, an open bite tendency and obesity. 
Cephalometry can be useful for estimating the volume of the tongue, 
nasopharynx and soft palate but not the oropharynx or hypopharynx.
Tongue posture appears to have a substantial effect on upper airway 
structures. On the basis of cephalometric studies, it has been shown that 
tongue cross-sectional area increases and oropharyngeal cross-section 
decreases when the OAS patients change their body position from upright to 
supine (Lowe, 1993).
A further study by Lowe et al (1995), using 80 subjects with OS A and 25 
controls, found that a higher apnoea index was seen in subjects in 
association with large tongue and soft palate volumes, a retrognathic 
mandible, an anteroposterior discrepancy between the maxilla and the 
mandible, an open bite tendency and obesity.
1.9 Prevalence of Obstructive Sleep Apnoea
In a study of the clinical features of obstructive sleep apnoea, Whyte et al 
(1989) reported that up to the time of his study OS A was considered rare in 
the U.K. However, an increase in referral rate from 19 patients in year 1 of 
the study to 61 patients in year 4 suggested that the prevalence of this 
disease had been underestimated. Costello (1996) reported that the 
question of excessive daytime sleepiness and driving was examined in a 
report published in 1996 by the Transport Research Laboratory,
(Department of Transport). Conclusions were based on interviews with 
1000 Heavy Goods Vehicle drivers and 4600 car drivers and found that 
drivers who snored were twice as likely to have an accident as non-snorers.
The predictors and prevalence of obstructive sleep apnoea and snoring were 
investigated in 900 men over a four-year period by Stradling and Crosby
(1991). Questionnaires were used as well as overnight oxymetry. The 
results showed a prevalence of symptomatic sleep apnoea of 0.3% for men 
aged 35-65 years of age, which means that each chest physician covering 
150,000 people (the recommended ratio in Britain) should have about 100
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such male patients. These figures suggest a total of approximately 36,000 
patients in the U.K. The prevalence in women compared to men was 1:15.
A report from the Royal College of Physicians (1993) on sleep apnoea and 
related conditions stated “estimates of the prevalence of OS A depend on 
age and sex of the population surveyed, the method of sampling and the 
criteria used for diagnosis” and suggested a prevalence of approximately 4% 
in middle aged men and 2 % in women, (Young et al, 1993).
Douglas (1994) described sleep apnoea as one of the commonest medical 
conditions in the United Kingdom that would be missed until all physicians 
remembered to ask about daytime sleepiness and loud snoring whenever 
they were taking a history.
1.10. Snoring and Sleep Apnoea in Special Groups
1.10.1 Children
Upper airway obstruction with snoring is commonly seen in children of all 
ages and is similar to that seen in adults (Guilleminault et al, 1978).
Enlarged tonsils and adenoids is the most common cause of airway 
obstruction in infants and children.
1.10.2 The Elderly
There is a high prevalence of sleep apnoea in the elderly, and it has been 
suggested that this may be one mechanism contributing to sleep-related 
mortality. Block (1981) suggested that predisposition to snoring and the 
consequent sleep disordered breathing and oxygen desaturation had been 
neglected in considering the important risk factors for mortality. The 
prevalence of every-night snoring appears to decrease after the age of 65 
(Cirignotta et al, 1989) but it is possible that the number of snorers are 
smaller due to an increase in mortality.
1.11 Associations between Snoring, Sleep Apnoea, and 
Specific Disorders
Associations have been found between snoring, sleep apnoea and other 
specific disorders; these include arterial hypertension (Lugaresi et al, 1980), 
heart disease (Koskenvuo et al, 1987a; Shepherd et al, 1991; Partinen and 
Guilleminault, 1990), brain infarction (Koskenvuo et al, 1987b; 
D’Alessandro et al, 1990), sudden death, (Shepherd et al, 1992).
1.11.1 Arterial Hypertension
An association between snoring and hypertension has been found (Lugaresi 
et al, 1980; Norton and Dunn, 1985; Koskenvuo et al, 1987a). In heavy 
snorers, pulmonary arterial pressure may increase to pathological levels 
during sleep. Systemic arterial pressure also increased slightly and reached 
the highest values during REM sleep (Lugaresi et al, 1994).
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1.11.2 Mortality
He et al (1988) calculated the cumulative survival in a study of 385 male 
patients with obstructive sleep apnoea and found that those with an apnoea 
index (Al) greater than 20 had a greater mortality than those with Al equal 
to or less than 20.
1.12. The Treatment of Snoring and Obstructive Sleep 
Apnoea.
Various remedies have been proposed to prevent snoring and there have 
been more than 300 patented devices in the USA alone. These remedies 
include taping a marble to the patients back, pyjama tops with a pocket 
sewn into them for a tennis ball, night-shirts with inserts to train the wearer 
to sleep on their side, special pillows, collars, chin straps, electric shocks, 
nasal devices and dental devices. Treatments of OSA using non-surgical 
methods include weight loss (Meyer and Knudson, 1990a), changes in sleep 
posture (Cartwright, 1984), drug therapy (Meyer and Knudson, 1990a), 
supplemental oxygen therapy (Meyer and Knudson, 1990a), nasopharyngeal 
tubes (Nahmais et al, 1987), continuous positive airway pressure (Sullivan 
et al, 1981), intra-oral and extra-oral devices. Surgical procedures (Sher et 
al, 1996) include correction of gross anatomical deformities, nasal 
septoplasty, uvulopalatopharyngoplasty (UPPP) (Fujita et al, 1981), and 
tracheotomy. Treatments have aimed to increase upper airway dilator tone, 
reduce the closing pressure by making the airway less collapsible, increase 
upper airway pressure above the closing pressure, and improve the
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dimensions of the upper airway. Combinations of these treatments have 
also been tried to produce both normal sleep and breathing.
1.12.1 Conservative Treatment; Weight loss
A loss of weight is considered by many authors as the first form of therapy 
for mild to moderate symptoms. Lowe (1993) demonstrated that the 
tongue and soft palate volumes increase as the body mass index increases, 
which supports weight loss as a treatment for OSA. However, there has 
been some suggestion that there is no direct relationship between the degree 
of obesity and OSA (Meyer and Knudson, 1989).
1.12.2 Sleep Posture
Snoring and sleep apnoea are usually worse while sleeping in the supine 
position and it has been reported that a change in sleep posture from supine 
to the lateral decubital position can reduce the tendency for airway relapse 
(Cartwright, 1984; Cartwright et al, 1985). Changing sleep position may 
have some validity, particularly in patients who have position related 
obstruction, or who are close to their ideal weight.
1.12.3 Drug Therapy
There are a number of drugs, which have an influence on the upper airway 
muscle activity. Alcohol and sedatives are associated with decreased upper 
airway muscle tone and can induce sleep-disordered breathing.
A number of pharmacological treatments have been proposed which include 
strychnine and nicotine. Progesterone is a recognised respiratory stimulant 
and has been found to be beneficial in treating OS AS. However, there are 
major side effects in male patients such as feminization, decreased libido, 
impotence and alopecia. The high dosage (60-120mg/day) also makes the 
treatment expensive. Other drugs that have been used are acetazolamide, 
protriptyline and theophyiline, which are all respiratory stimulants. 
Protriptyline appears to be effective in reducing the amount of REM sleep, 
the stage in which apnoeas tend to last longest. Complications, including 
urinary retention and anticholinergic effects, have been reported in 60%- 
100% of patients by Meyer and Knudson (1990). The use of supplemental 
oxygen may have the effect of prolonging apnoeas by removing the major 
stimulus (hypoxemia) for their termination.
1.12.4 Continuous Positive Airway Pressure (CPAP)
The use of continuous positive airway pressure (CPAP), first described by 
Sullivan et al (1981), is the most common and most effective treatment for 
obstructive sleep apnoea (Clark et al, 1996a). Wali and Kryger (1995) 
considered the use of CPAP as the treatment of choice for obstructive sleep 
apnoea, a view widely shared by sleep physicians. Berry and Block (1984) 
proposed the use of CPAP as a treatment for snoring in patients who had no 
symptoms of OS AS. Nasal CPAP is thought to act as a pneumatic splint 
for the nasopharyngeal airway. Low levels of pressure are applied via a 
nasal mask to prevent upper airway closure.
Nasal CPAP is a relatively safe mode of therapy and is generally well 
tolerated although Clark et al (1996a) reported that between 10 to 50 % of 
patients treated with CPAP find it uncomfortable and discontinue use after a 
short period of time. Others have suggested that about 25% of patients 
may not tolerate CPAP (Riley et al, 1990; Lyon et al, 1992; Wali and 
Kryger, 1995). Common minor complications include dryness of the upper 
airway, sneezing, nasal drip, nasal congestion, local skin irritation, eye 
irritation, sinusitus, and nosebleeding. The patient is required to wear the 
mask throughout the night and it can be uncomfortable and inconvenient to 
use and is not aesthetically acceptable.
Alternatives to nasal masks are nasal pillows that insert tightly into the 
nares or a mask that goes over the mouth and nose. Another model is 
called BEPAP (Bi-level Positive Airway Pressure) which delivers a higher 
pressure during inspiration and a lower during expiration. However, Riley 
et al. (1990) suggests that 35 % of patients discontinued this form of therapy 
after only five months.
A randomised crossover trial of 32 patients compared CPAP directly with a 
placebo. This study found improvement in multiple sleep latency time and 
vigilance but no significant difference in patient preference after one month 
follow up (Engleman et al, 1997). CPAP is said to be used for 3 to 7 hours 
per night, Engleman et al. (1996). Cobb and Rommerdale (1996) reported 
that in approximately 20 % of patients who use CPAP, air is forced through
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the nostrils but escapes through the mouth rather than being forced past the 
obstruction. Their solution to this problem was to use a custom oral device 
to prevent air escape from the mouth, which was worn in conjunction with 
CPAP.
1.13 Surgical Treatments
The efficacy of surgical therapy in adults with obstructive sleep apnoea was 
reviewed by Sher et al (1996) for the American Sleep Disorders 
Association. Operations to treat snoring and obstructive sleep apnoea 
syndrome include surgery to the nose, uvula and soft palate, tongue and 
changing the skeletal relationship and include nasal septal reconstruction; 
uvulopalatopharyngoplasty; uvulopalatopharyngoglossoplasty; laser midline 
glossectomy; lingualplasty; inferior sagital mandibular osteotomy and 
genioglossal advancement, with hyoid myotomy and suspension (GAHM); 
maxillomandibular osteotomy and advancement, and tracheotomy. More 
recently, laser-assisted uvulopalatoplasty has been advocated (Ryan, 1997).
1.13.1 Mandibular Advancement
A low hyoid bone or a posterior position of the mandible result in posterior 
positioning of the tongue, thus reducing the posterior airway size. Riley et 
al (1990) reviewed 40 patients treated with maxillary, mandibular and hyoid 
advancement and reported that snoring was eliminated in all but three 
patients. They claimed a success rate of 97% in correcting OSA.
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However, results from a study by Miles and Nimkam (1995) indicated that 
OSA did not appear to be associated with abnormal presurgical mandibular 
morphology.
1.13.2 Uvulopalatopharygoplasty
Uvulopalatopharygoplasty involves removal of the uvula and part of the soft 
palate to tighten the soft tissues in an attempt to reduce the amount of 
vibration of these tissues. The success rate for this treatment has been 
defined as a 50% reduction in apnoea index and was of the order of 
50-60 % (Fujita et al, 1981). Saunders et al (1989) reported on eighteen 
patients who had UPPP surgery as a treatment for snoring. These patients 
were followed up for three to eight months and snoring was eliminated in 
one case and there was a reduction in noise in fourteen. However, 
recurrence of apnoea frequently occurs after 1 -2 years which suggests that 
the procedure does not treat the underlying cause of snoring or apnoea.
There is significant postoperative pain as well as possible postoperative 
stenosis and infection. An excessive resection during UPPP could result in 
palatopharyngeal insufficiency with resulting hypemasal speech and nasal 
regurgitation. Uvulopalatopharyngoglossoplasty (UPPGP) is an operation 
that incorporates a modified UPPP together with limited resection of the 
tongue base.
Laser Assisted Uvulopaloplasty (LUAP) consists of shrinking the soft 
tissues by scarring and tightening and so no tissue is usually removed.
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Current data do not support the efficacy of LAUP in sleep related breathing 
disorders, although it may be of more relevance in the treatment of snoring 
(Ryan, 1997).
1.13.3 Tracheotomy
Tracheotomy refers to the creation of a percutaneous opening into the 
trachea. Tracheotomy was the treatment of choice for obstructive sleep 
apnoea but with the introduction of other forms of treatment, particularly 
CPAP it is rarely used these days.
1.14 Treatment of Snoring and OSAS with Non-Dental 
Devices
There are many non-dental devices to stop snoring; the majority concentrate 
on improving breathing through the nose. These include nasal dilator 
devices, such as the Nosovent described by Petruson (1988; 1990), and are 
made in flexible plastic (Nosovent) or stainless steel wire (Snore-no-More). 
They are inserted in the anterior part of the nose to dilate the nostrils. An 
external nasal dilator is also available (Breath Right nasal strip). These 
nasal strips have proved popular as a nasal dilator with sportsmen such as 
American Football players, rugby players, and footballers to improve their 
breathing while playing. However, the effect of these strips to prevent 
snoring is not supported by clinical trials.
44
Nasopharyngeal tubes placed beyond the clinical obstruction can have a 
positive effect in OSA patients. A 2.5-3.3 mm paediatric endotracheal tube 
is inserted to a level of 5 mm above the epiglottis with the aid of fibreoptic 
visualisation. This treatment can be used temporarily while the patient 
achieves the necessary weight loss. Nahmais et al (1987) reported on seven 
patients who were treated with this method, although two were unsuccessful 
because of mucous plugging of the tube. However, Meyer and Knudson 
(1990a) reported that most patients refused long-term nasopharyngeal tubes 
because of chronic irritation, pain, and possible hypertrophy of tissue that 
may occlude the tube.
Cartwright et al (1985) suggested sleep position training as a treatment for 
sleep apnoea syndrome. Ten male patients were trained to avoid the back 
sleeping position by wearing a gravity-activated position monitor/alarm on 
the chest. This device emitted an auditory signal if the patient remained on 
his back for more than ten seconds. The number of apnoeic events was 
significantly reduced, as were the number of periods of significant oxygen 
desaturation.
1.15 Treatment of Snoring and OSAS with Dental Devices
Various dental devices have been reported to have an effect on reducing 
snoring and OSA (Clark, 1988; Clark and Nakano, 1989; Paskow and 
Paskow, 1991; Lowe, 1994; Schmidt-Nowara et al, 1995, Clark et al,
1996b, Loube and Strauss, 1997).
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The most common appliances are those which prevent the tongue from 
adopting a retruded position and appliances which reposition the mandible. 
All appliances that reposition the mandible also have an effect on retaining 
the tongue in a forward position. There are also two devices of similar 
design, which are specifically for treatment of snoring and apply to the soft 
palate tissues (Paskow and Paskow, 1991; and Wagner and Price, 1987). 
The tongue retaining appliances include the tongue retaining device 
(Cartwright and Samelson, 1982), the tongue locking devise (Princell et al, 
1992), and the tongue positioner and exerciser (Lowe, 1993).
The mandibular positioning appliance has been described in various forms 
by Meier-Ewert and Brosnig (1986), Soil and George (1985), George et al
(1992), Schimdt-Nowara et al (1991), Nakazawa et al (1992), Clark et al
(1993), Eveloff et al (1994), Reimao et al (1994), Yoshida (1994), Osseiran 
(1995), O’Sullivan et al (1995) and Menn et al (1992). Many of these 
appliances have been patented and are known by trade names such as the 
Equaliser, (Nahmais et al, 1987), Nocturnal airway patency device or 
NAPA, (George, 1987), Sleep and nocturnal obstructive apnea reducer or 
SNOAR, (Viscomi et al, 1988) and Snoarguard (Schmidt-Nowara et al, 
1991).
A review of 13 appliances by Lowe (1994) evaluated 246 subjects with 
snoring and 456 subjects with OSA.
Schmidt-Nowara et al (1995) reviewed 21 publications describing 320 
patients treated with oral appliances and concluded that oral appliances 
presented a useful alternative to CPAP. These appliances were especially 
for patients with simple snoring and patients with mild to moderate 
obstructive sleep apnoea who cannot tolerate CPAP therapy. A later survey 
(Loube and Strauss, 1997) of dentists treating obstructive sleep apnoea 
patients listed twenty-five different oral appliances used among members of 
the Sleep Disorders Dental Society of which only 11 of the 25 had been 
evaluated using pre-treatment and post treatment polysomnography.
The American Sleep Disorders Association in 1995 provided clinical 
guidelines and recommendations on the use of oral appliances for the 
treatment of snoring and obstructive sleep apnoea.
1.16 Tongue Retaining Oral Appliances
1.16.1 The tongue retaining device
The tongue retaining device (TRD) (Cartwright and Samelson, 1982), 
(Figure 1.1) was designed to hold the tongue forward during sleep. It was 
made of a soft co-polymer, in the form of a bi-maxillary mouthguard, and 
holds the tongue by suction in a bubble or cup positioned between the 
anterior teeth. The device holds the mandible in an open position of 
approximately 15 - 20 mm between the incisor teeth but there is no 
protrusion.
Cartwright and Samelson (1982) reported the TRD to be effective in a study 
of 20 patients, 14 of whom had polysomnography on two nights, three 
patients had not been followed-up and three could not tolerate the 
appliance. Patients were evaluated with and without the device on each 
night of monitoring. The number of apnoea episodes was cut by half with 
the number of oxygen desaturation episodes reduced from 44 to 25. A 
disadvantage of the TRD was that the retention of the tongue was not 
always effective, most subjects could wear the device for 3 to 4 hours 
before suction was lost. Another disadvantage is aesthetic, as the tongue 
must protrude between the teeth. The TRD forces nasal breathing, which 
may be difficult for some patients, although the appliance can be modified 
by the addition of lateral airway tubes. The tongue can also become 
irritated from the restricted blood supply.
A study by Adachi et al (1993), reported that genioglossus muscle activity 
and the relation to inspiratory effort is of physiological importance to OSA 
patients. A TRD helps compensate for the altered genioglossus muscle 
activity during inspiration by bringing the tongue forward.
A single case study was reported by Alvarez (1992) of a patient who had 
failed treatments with surgery and CPAP and by Farrow (1991) of two cases 
of central sleep apnoea that had been treated with a tongue retaining device.
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1.16.2 The Tongue Locking Device
The tongue locking device is a pre-formed elastic device available in 
different sizes (small, medium, large) that provides a cavity for the tongue 
and holds it forward during sleep (Princell et al, 1992). Lateral breathing 
holes assist airflow if nasal obstruction occurs. An evaluation of ten 
subjects found that five had a reduction of Respiratory Distress Index and 
five individuals became worse with the tongue locking device in place.
1.16.3 The Tongue Positioner and Exerciser
This device contacts the upper and lower teeth with a ramp at occlusal plane 
height invented by Richard North and is designed to “retain the tongue and 
musculature to be in the proper rest and saliva swallowing position”. The 
appliance opens the jaw by 1-1.5 mm and the mandible is not advanced 
(Lowe, 1994). No published outcome data are available.
1.16.4 The Tepper Proprioceptor Stimulator (TOPS)
This appliance was designed by Tepper and is fitted to the maxillary arch 
with a posterior tongue extension which is held inferiorly with an elastic 
band (Lowe, 1994). It has a padded bar lingual to the incisors to direct 
tongue placement. The aim is to strengthen the tongue, particularly the 
dorsal muscles, and reposition the tongue against the hard and soft palate to 
create more airway space. There are no outcome data to date
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Figure 1.1 The tongue-retaining appliance (Cartwright and Samelson,1982). 
The tongue is held by negative pressure in the soft acrylic bulb.
Figure 1.2 The mandibular positioning appliance (Meier-Ewert and Brosnig 
1986). This type of appliance was based on functional orthodontic 
appliances.
50
1.17 The Mandibular Repositioning Appliances
Johnson et al (1992) has reported airway changes at the level of the 
oropharynx and hypopharynx when the mandible is postured anteriorly. A 
mean increase of the posterior airway space of approximately 56% was 
recorded in their study of ten patients, although there were wide variations. 
The mandibular positioning appliances reposition the mandible in a 
forward, open position, which also brings the tongue forward and so 
enlarges the retroglossal space. Stradling et al (1998) suggested that an 
alternative explanation for the effect of mandibular repositioning appliances 
might be that by “pulling the mandible forward the lateral walls of the 
pharynx could be made taut and would therefore be less likely to vibrate or 
collapse, without necessarily increasing the retroglossal space or lowering 
upper airway resistance”.
The effectiveness of these appliances was reported by Clark and Nakano 
(1989) to be greater than 85% in patients with OS A. There are a number of 
variations of design but a consistent feature is that the mandible is moved 
forward by several millimetres, being between 50%-75% of the maximum 
protrusive opening (Clark et al, 1996a). The success of these appliances 
depends on their ability to maintain the jaw in a forward position even 
though the patient is asleep. Appliances that position the mandible 
forward are either one-piece designs that cannot be adjusted or they are two- 
piece and are adjustable.
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1.17.1 The Mandibular Positioning Appliance
The first rigid repositioning appliance that was effective in reducing OSA 
was first described by Meier-Ewert, Schafer and Klob in 1984 at the 7th 
European Sleep Congress and subsequently by Meier-Ewert and Brosnig
(1986). In a group of seven subjects the mean AHI was reduced from 38 to
12.1 after wearing the appliance.
In a larger study of 44 subjects by Lowe (1993), a reduction of mean Al 
from 50.4 to 23.1 was recorded. The design of these appliances was based 
on a monoblock functional appliance, again used in orthodontics to advance 
the mandible and promote forward growth (Figure 1.2).
Bonham et al (1988) described a modified functional appliance in patients 
with obstructive sleep apnoea. Of twelve patients fitted with the appliance, 
ten had a decrease in the total apnoea index from a mean of 53.82 to 35.99 
events per hour.
Another device was described by Menn et al (1996). This consisted of full 
maxillary and threequarter mandibular coverage acrylic splints joined with 
acrylic resin pillars. These pillars which were not permanently fixed and 
thereby allowed for serial modification of mandibular protrusion and jaw 
separation. Of 29 patients fitted with the device, 16 showed a decrease in 
respiratory disturbance index.
1.17.2 The Nocturnal Airway Patency Appliance (NAPA)
This appliance, which is a fixed one-piece design, is a modified functional 
appliance and advances the mandible about threequarters of maximum 
protrusion. The device was first described by Soil and George (1985), and 
was used for one patient. This appliance is designed to keep the airway 
open during sleep by positioning the tongue more anteriorly and inhibiting 
wide jaw opening while still assuring adequate intake of air through the 
mouth whenever nasal obstruction occurs. This air supply can be via an 
external breathing “beak”. The appliance is constructed in acrylic with as 
many as eight Adam’s cribs for retention. All the teeth must be firmly held 
in acrylic, with the acrylic overlapping the facial and lingual surfaces of the 
teeth. The NAPA rigidly stabilises the mandible in both the horizontal and 
vertical directions. A study of five subjects that was reported by George
(1987), while a retrospective study by George et al (1992) showed an 
average respiratory disturbance index of 42.2 which was reduced by 78 % 
when wearing the appliance. This study supported the contention that a 
low hyoid bone relative to the mandibular plane is an etiological factor in 
snoring and OSA.
1.17.3 The Sleep and Nocturnal Obstructive Apnea Reducer
The SNOARTm open airway appliance is an acrylic mandibular positioning 
appliance that advances the mandible 6-9 mm and opens it vertically 17 mm 
or more.
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When the mandible is moved anteriorly and inferiorly, the tongue is 
correspondingly repositioned anteriorly away from the posterior wall of the 
pharynx and inferiorly from the soft palate (Lowe, 1994). Viscomi et al
(1988) reported the treatment of snoring and sleep apnoea in six patients 
using a SNOARTm device. In this limited study using the appliance the RDI 
was reduced from 45.5 to 9.7 and snoring was absent. All patients were 
evaluated using polysomnography.
1.17.4 The Snoar Guard
The Snoar Guard (Therasnore appliance) is a prefabricated device which is 
placed in hot water and moulded to fit the patient. The appliance covers 
only the anterior teeth and is lined with soft polyvinyl for comfort. The 
mandible is positioned 3 mm behind maximum protrusion with a opening of 
approximately 7 mm. Schmidt-Nowara et al (1991) found that snoring was 
eliminated in 6 out of 14 patients and reduced in 8. After 7 months of use in 
68 patients, 75 % used the appliance regularly. Snoring was decreased in 
67 subjects and eliminated in 29 of these.
Ferguson et al (1996) used the Thereasnore in a randomised crossover study 
of an oral appliance versus nasal CPAP in the treatment of mild to moderate 
OSA patients and concluded that an oral appliance was effective in some 
patients and was associated with fewer side effects and greater patient 
satisfaction than nCPAP. This appliance has subsequently been redesigned 
to allow adjustment in increments of 1.5mm.
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1.17.5 The Equaliser
The Equaliser was designed to position the mandible forward, equalise 
intra-oral and extra-oral air pressure, and elevate the soft palate without 
impairing nasal breathing (Haze, 1987a). A study of 14 patients treated 
with the Equalizer reported a mean RDI of 36.5 before reduced to 18.9 
(Haze, 1987b).
1.18 Adjustable Appliances
Adjustable appliances allow the mandibular advancement to be adjusted if 
required. A variety of designs are available which generally use pre­
formed attachments. Some of these designs also allow opening of the 
mandible.
1.18.1 The Herbst Appliance
The Herbst appliance (Figure 1.3) has been used for many years in 
orthodontics to encourage growth of the mandible. In 1988, Rider 
described the use of a Herbst appliance for the treatment of sleep apnoea. 
In a study of 16 patients over a 10 month period, 15 patients showed 
improvements of 70 to 100 per cent (one could not tolerate the appliance).
Clark et al (1993) described the use of an anterior mandibular positioning 
device that consisted of upper and lower acrylic bases held in position by 
two Herbst attachments.
These allowed opening, protrusion, and some lateral movement but no 
retrusive movement. Bilateral inter-arch elastics were used to keep the jaw 
closed, with interproximal ball end clasps to retain each individual 
appliance firmly in position. The appliance advanced the mandible by 5-7 
mm, or at least 75% of maximum protrusion. After 36 months, 15 of 24 
subjects were still wearing the appliance. The mean respiratory disturbance 
index before treatment was 48.4 ± 33.4, and was 12.0 ±21.3 after the 
treatment. Eveloff et al (1994) also reported on the use of Herbst 
mandibular appliances in 14 subjects who were not able to tolerate CPAP, 
but the Herbst appliance was successful after a two-year follow up.
In a study by Sjoholm et al (1994), a Herbst appliance was compared to a 
muscle relaxation appliance that covered the maxillary teeth but produced 
no protrusion. The Herbst appliance was adjusted to achieve 50% of 
maximum protrusion. The Herbst appliance did bring about some 
alleviation of upper airway obstruction, but did not lead to sufficient control 
of apnoea. However, the muscle relaxation appliance also reduced partial 
upper airway obstruction. The explanation offered was that this effect 
could have been secondary to the discomfort arising from the appliance, this 
discomfort, leading to increased sleep fragmentation and reduced relaxation 
during sleep.
A Herbst appliance was also used in a cross-over study with the efficacy 
CPAP (Clark et al, 1996a). The oral device was successful in most cases 
but was less effective than CPAP, especially for the more severe cases.
In general, the oral device was strongly preferred to CPAP.
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A variation of the Herbst appliance, the Jasper Jumper, was also used to 
position the mandible forward (Lowe, 1994). However, the appliance did 
not generate enough forward force to overcome the muscle pull on the 
mandible.
1.18.2 The Silencer
Halstrom (1994) described this appliance as consisting of upper and lower 
splints articulated by means of a commercially pure titanium hinge (Figure 
1.4). This permits the incremental advancement of the mandible through a 
range of 10 mm by a series of five holes. It also provides a lateral 
movement of 6 mm and a 1mm vertical movement while the mandible is in 
the desired protrusive position. There is a recommended registration 
technique provided with this system in the form of a modified Gothic Arch 
tracing to position the hinge correctly. This appliance was used in a short­
term controlled trial of an adjustable appliance to CPAP for the treatment of 
mild to moderate sleep apnoea in 24 patients (Ferguson et al, 1997). Of 20 
patients who completed the study, 11 were treatment successes (reduction 
of AHI to <10/hour and relief of symptoms), one was a compliance failure 
and eight were treatment failures (failure to reduce AHI to < 10/hour or 
relieve symptoms). Fourteen of the 20 who used CPAP were treatment 
successes with six compliance failures.
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Six patients with OSA were treated with a Silencer and titration of the 
appliance was completed during one night of polysomnography 
(Raphaelson et al, 1998). The device was adjusted until snoring, oxygen 
desaturations and apnoeas were improved. Patients were instructed to 
sleep in the supine position until they had completed the first period of 
REM sleep or 2 hours if the patient did not enter REM sleep. It was 
suggested that there was generally an under-estimate of the amount of 
anterior mandibular repositioning required.
1.18.3 The Thornton Adjustable Positioner (TAP)
Described by Thornton and Roberts (1996), this device uses a single latch 
and hook which restricts all retrusive movement but allows the patient 
forward and lateral movement. The amount of protrusion can be adjusted 
by turning the hook, which is attached to a screw that extends extra-orally. 
In a telephone survey of 208 of 300 patients who had worn the appliance for 
6 months, 81% were said to use it for 25 days per month. They also 
reported that only 4 patients out of the 208 felt that the appliance had not 
improved their snoring.
1.18.4 The Klearway Appliance
The Klearway appliance is a patented device that consists of upper and 
lower arch splints connected by a Hyrax expansion screw. This allows 11 
mm of mandibular advancement in 44 separate 0.25 mm increments.
The appliance also uses a temperature sensitive resin which is softened in 
hot water before insertion to provide increased retention and to reduce tooth 
discomfort. The hinge position was then adjusted. Five out of six 
patients reported improvement with the appliance in positions changed from 
the baseline position. This device permits lateral and vertical jaw 
movement, which enables patients to yawn and swallow without dislodging 
the appliance.
This appliance is currently being used in a long term multicentre clinical 
trial comparing it with CPAP in a large population of OSA patients (Lowe 
et al, non published data). A total of 270 patients were to be recruited for 
the trial with covert compliance monitors used in both the appliance and 
CPAP (Lowe et al (a), personal communication). A preliminary report on 
10 OSA patients who had polysomnography before and after using the 
Kleerway showed a reduction in RDI of all patients (Lowe et al, (b) 
personal communication).
1.18.5 The Silensor
This appliance (E.M.Natt Ltd, England) is similar in principle to a Herbst 
appliance, the difference being that two plastic rods (two different sizes 
available) are used with upper and lower thermoformed splints (Figure 1.5). 
A study of 29 patients with mild or moderate apnoea were fitted with this 
device in a randomised crossover study with CPAP (Tan et al, 1998). It 
was found that the Silensor was as effective as CPAP.
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Figure 1.3 Herbst appliance. The rod and tube prevent posterior movement 
o f the mandible and allow opening. The completed appliance would have 
inter-arch elastics on the anterior to limit excessive mouth opening.
Figure 1.4 Silencer appliance. The appliance can be titrated by means of 
the hinge (lower) and holes (upper) by 5 increments up to a maximum of 
10mm.
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1.19 Other Mandibular Repositioning Appliances
A variety of other mandibular positioning appliances have been described 
which include the use of both hard acrylic and soft polyvinyl materials. A 
device was described by Ichioka et al (1991) in a preliminary study of 12 
male and 2 female patients. The device was an acrylic splint fitted to upper 
and lower teeth that advanced the mandible 5 to 7 mm. The upper teeth 
were securely held but the lower teeth were loosely held. When the 
patient’s mouth opened during sleep the lower teeth were easily released 
from the splint but when the patient’s mouth closed the lower teeth slid into 
the lower part of the sleep splint and the mandible was moved forward. 
Evaluation was by polysomnography. A 50% reduction in Al was found in 
13 of the 14 patients.
A hard acrylic appliance was described by Knudson et al. (1992) which was 
made to an incisal edge-to-edge position with 12-15 mm opening. 
Cephalograms were used to evaluate spacial change between the base of the 
tongue and the pharyngeal wall. In two cases described the RDI was 
reduced from 42 to 9 in one and from 18 to 3 in the other (Knudson and 
Meyer, 1993). Wong et al (1992); Nakazawa et al (1992) and Osseiran 
(1995) have also described this procedure.
Athanasiou et al (1994) described an appliance used for 45 patients 
consisting of a one-piece acrylic device that fitted over all the lower teeth 
and the upper posterior teeth, with Adam’s cribs and a labial bow for 
retention.
Lateral cephalograms were taken to evaluate the position of the pharynx, 
soft palate, adenoid tissue, tongue, and hyoid bone before and after wearing 
the device. The results indicated that significant changes in pharyngeal 
space, hyoid bone and tongue position takes when a mandibular positioning 
device is used. A 40-year-old male was treated with an orthodontic 
appliance, the Bionator Basic, for obstructive sleep apnoea (Reimao et al,
1994). A significant improvement of excessive daytime sleepiness and 
decrease in apnoeas was recorded.
O’Sullivan et al (1995) described a mandibular advancement splint (MAS), 
that maintained an inter-arch separation of approximately 10-mm at 75% of 
maximal protrusion used to treat 57 patients with habitual snoring, 39 of 
whom had OSA. The appliance was made in polyvinyl acetate 
polyethylene. The design of this device differed from most appliances in 
that it was in contact with all the teeth except the upper anteriors. Snores 
per sleep minute, corrected for time in apnoea, sound intensity of snores (% 
snores >50dB) decreased with the MAS from 11 ± 5.8 and 42.0 ± 25% to 
9.0 ± 6.0 (p< 0.001) and 26.2 ± 25.2 (p<0.001) respectively.
Cohen (1995) described a variation in design of a mandibular positioning 
appliance. This appliance consisted of thermoformed soft vinyl coverage 
of the teeth and soft tissues with a polymethyl methacrylate wafer to 
maintain the registered jaw position. This position was usually with 5-6 
mm of protrusion and an opening of 5-8 mm.
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A vacuum formed appliance was also used by Stradling et al (1998) for the 
control of snoring in a retrospective study in a highly selected group of 
patients (n = 15) who had worn a mandibular advancement device and had 
reported subjective improvement to their symptoms. Home monitoring 
over two nights with and without the appliance showed that the appliance 
did make a difference to the frequency of snoring and the level of noise.
Menn et al (1992) reported on the use of a mandibular advancement device 
in 19 patients. Evaluation involved cephalometric radiographs, CT 
scanning of the TMJ and polysomnography. Their results showed a 
significant improvement in the apnoea index, nocturnal oxygenation, and 
reduction in daytime sleepiness.
All of the appliances so far discussed have been for dentate patients, but an 
appliance that can be used in edentulous patients has been described (Meyer 
and Knudson, 1990b).
Knudson and Meyer (1993) reported on the use of an appliance for one 
edentulous patient. The result was a reduction of obstructive episodes from 
111 to 14 and the respiratory index dropped from 18 to 3. Robertson 
(1997) also described a single case where a similar device was used.
1.20 The Adjustable Soft Palate Lifter
This device is only for the treatment of snoring and was described by 
Paskow (1988) and Paskow and Paskow (1993), (Figure 1.6). The device 
is worn in the upper arch with a soft palate lifting portion that may be 
adjusted in all three dimensions.
Wagner and Price (1987) described a similar device. However, both these 
devices were used on single case studies without any objective follow-up 
measure and problems with gagging are significant.
1.21 Other Dental Devices
Seifert (1980) described a device that prevents air being inhaled through the 
mouth whenever it opens. This device consists of a soft acrylic sheet of 1- 
mm thickness that fits between the teeth and lips. The restriction of air 
through the mouth is intended to cause the sleeping person to change 
position without losing depth of sleep.
A device described as a labial shield (Campion, 1985) was reported to 
prevent or restrict oral airflow, thereby forcing nasal breathing to reduce 
snoring. The labial shield (Snore-no-more, Dentec Australia Pty Ltd) is 
intended to prevent or restrict oral airflow, thereby forcing nasal breathing. 
However, a study by Bushell et al (1991) of 14 patients with a history of 
chronic snoring concluded that snorers using this device were unlikely to 
experience any benefit.
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The device did not change the mean frequency or intensity of snores 
although the number of disordered breathing events per hour of sleep 
decreased by approximately one third.
There are also a large number of commercially available oral devices 
advertised for direct sale to the public but none so far have been subjected 
to clinical trials.
In evaluating the choice of dental appliance, the American Sleep Disorders 
Dental Association listed properties of the “ideal” intraoral appliance 
(Barsh, 1996) which included:
• Produce minimal damage to the teeth and periodontium;
• Produce no changes in perception of occlusion after its removal and not 
create TMJ dysfunction:
• Be considered a long-term appliance; therefore, there should be no 
adverse effects on the teeth, periodontium, occlusion, or TMJ over many 
years.
Fleetham et al (1996) was of the opinion that mandibular advancement 
appliances require at least 10 teeth in each of the maxillary and mandibular 
arches and that in addition to advancing the mandible they also produce 
downward rotation of the mandible.
1.22 Outcome measures for oral appliances
A medical and dental history and examination, polysomnography, 
radiographs and patient/partner questionnaire are the standard method of 
evaluation.
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Another method of evaluation is the use of image intensification 
fluoroscopy (IIF) in conjunction with tooth guided mandibular protrusion 
with the patient in the supine position (L’Estrange et al, 1995). This 
method enables the study of the adaptive behaviour of patterns of oral and 
oropharyngeal structures in response to mandibular advancement and thus 
may determine whether an advancement splint may be effective. It is 
claimed that IIF is as useful as cephalometric analysis (L’Estrange et al,
1995).
For patients with primary snoring without features of OSA or upper airway 
resistance syndrome, the subjective assessment (usually by partner) is 
appropriate.
However, there have been a number of studies where oral appliances have 
been effective in reducing snoring but OSA have been worse when an 
objective measure was used.
A study by Clark et al (1993) showed that of fifteen patients who had 
follow-up polysomnography, fourteen had a reduction of RDI but one had 
an increase. This was also shown by Schmidt-Nowara et al. (1991), where 
one patient in twenty did not show a reduction in AHI. Bonham et al 
(1988), and Eveloff et al (1994) also reported that one patient in fifteen in 
each study had a worse AHI on follow-up.
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The American Sleep Disorders and Sleep Research Report in 1995 
recommended that although polysomnography was not indicated for 
patients with either primary snoring or mild OSA, patients treated with oral 
appliances should return at regular intervals. It would appear to be 
important that diagnosis by a sleep physician is carried out before referral to 
a dentist for an oral device.
1.23 Summary of Review of Literature
Obstructive sleep apnoea with associated snoring is one of a number of 
sleep breathing disorders and is a potentially serious condition with a high 
morbidity. Problems associated with these conditions are excessive 
daytime sleepiness and increased risk of stroke and heart disease. A study 
by He et al (1988) suggested that subjects with OSA (AHI > 20) have an 
increased risk of mortality. A study by Young et al (1993) suggested a 
prevalence of OSA of 2% for women and 4% for men. Sleep disordered 
breathing may be as prevalent as asthma and diabetes and is a rival to 
smoking as a major public health problem (Phillipson, 1993), although 
sleep disordered breathing remains largely misdiagnosed in most patients, 
(Fleetham, 1997).
Of the treatments currently available there are four routes open.
1. Behavioural
2. Continuous positive airway pressure
3. Surgery
4. Oral Appliances.
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Figure 1.5 The Silensor appliance. The plastic rods allow opening while 
preventing retrusion of the mandible.
Figure 1.6 Soft palate lifter appliances. The adjustable (left) design by 
Paskow (1988) and non-adjustable by Wagner and Price(1987).
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No one treatment fits all patients (Cartwright, 1997), therefore it is 
important that accurate diagnosis by a sleep physician is made before the 
decision on the appropriate treatment is made.
Conservative or behavioural treatments include weight loss, sleep position 
training and reduced alcohol and tobacco consumption. The “gold 
standard” therapy among sleep physicians is nasal CPAP. Surgery may 
range from simple nasal surgery (deviated septum), to major oral surgery 
(maxillo-mandibular advancement). In a systematic review of published 
research from 1966-96, Wright et al, (1997) suggested that the relevance of 
sleep apnoea to public health was exaggerated with the effectiveness of 
continuous positive airway pressure poorly evaluated. It was suggested 
that patients with daytime sleepiness might benefit from large randomised 
placebo controlled trials of CPAP versus an effective weight reduction 
programme or other interventions.
The use of various intra-oral devices have been reported in the dental and 
medical literature. Studies by Clark et al (1996b), Ferguson et al 
(1996,1997), and Tan et al (1998) comparing the efficacy of CPAP with 
mandibular re-positioning reported that the oral appliances achieved 
substantial success in reducing the AHI, improving oxygen saturation, and 
improving sleep quality. Although the oral appliance was not as effective 
as CPAP, especially for the most severe cases, the oral appliance was 
strongly preferred by the patients.
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Following a review by Schmidt-Nowara et al (1995) of 21 papers, which 
included 320 patients treated with oral appliances, the American Sleep 
Disorders Association issued guidelines for the use of oral appliances in the 
treatment of snoring OSA. Despite considerable variation in the design of 
oral appliances used, the clinical effects were consistent. Snoring was 
improved and almost eliminated in patients who use an oral appliance.
OSA improved in the majority of patients. There appears to be a case for 
the use of such devices to treat snoring and mild OSA, and as a treatment 
therapy where patients reject CPAP.
There are two broad categories of intra-oral device; those which hold the 
tongue forward and the mandibular advancement device. Following the 
use of cephalometrics and computerised tomography to assess the success 
dental appliance therapy, Lowe (1993) concluded that the success of dental 
appliance therapy could not be predicted with a significant degree of 
accuracy based on anatomical considerations. There seems to be general 
acceptance that mandibular advancement devices achieve success by 
moving the lower jaw, tongue, soft palate and hyoid bone into a better 
position to help create a more patent airway. These appliances help to 
prevent airway closure during sleep by stabilising the lower jaw, tongue 
and hyoid bone. This type of appliance also gives the tongue an increased 
muscle tone, which makes the tongue less likely to cover the airway during 
sleep.
There is a large variation in the design of oral appliance and the choice of 
materials used. The first appliances were made of polymethyl 
methacrylate and were retained by wire clasps, but increasingly vacuum- 
formed blanks are used. As the first dental appliances were developed 
from functional appliances there were also devices which used traditional 
orthodontic attachments such as the Herbst rod and tube from the Herbst 
appliance and expansion screws for the Kleerway appliance. These 
appliances have the additional advantage that mandibular advancement can 
be titrated and allow the patient freedom of movement in vertical and 
lateral directions. Dental appliances will not be well tolerated by patients 
with temporomandibular joint dysfunction (Clark et al, 1996b). However 
mild joint problems may be lessened by the forward jaw position (Lyon et 
al, 1992).
Dental appliances can only be used for patients who are highly motivated, 
as the appliance may have to be worn during sleep for life, which is also 
true for CPAP.
Oral appliances may not always be effective, probably because of the 
combinations of different skeletal, soft tissue and functional factors that 
produce obstruction in the upper airway. Schmidt-Nowara et al (1995), 
and Schmidt-Nowara (1996), have reported that oral appliances are less 
effective when the respiratory distress index exceeds 40-50 events per hour.
This would suggest that oral appliances may be more suitable for snorers 
and mild to moderate OSA sufferers. Studies by Clark et al (1996b), 
Fleetham et al (1996) and Ferguson et al (1997) have compared oral 
appliances with CPAP and found that oral appliances were generally better 
tolerated than CPAP, although not as effective.
It is important that a sleep physician performs correct diagnosis before any 
treatment is undertaken. In some cases dental appliance therapy for mild to 
moderate OSA can be considered. Dental appliance treatment is simple, 
non-invasive, reversible, quiet and cost effective and may be the treatment 
of choice for simple snorers or for patients who are unable to tolerate CPAP 
or who are poor surgical risks.
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Chapter 2
MATERIALS AND METHODS
2.1 A Preliminary Test Appliance
A series of test appliances was worn by the author, a 43 year old male who 
had been a snorer for five years according to his wife (the author was 
unaware of snoring). These appliances were a rigid mandibular positioner, 
a semi-flexible mandibular positioner, an adjustable mandibular positioner 
using a Hyrax expansion screw, and two commercially available anti- 
snoring devices. The author reported no daytime sleepiness or breathing 
problems, although he was overweight with a body mass index of 29. The 
only medical treatment had been a nasal inhaler, which was unsuccessful.
The first appliance was a mandibular positioning appliance similar to that 
described by Soil and George (1985). This consisted of a modified 
functional orthodontic appliance used to reposition the mandible in a open 
position of 4 mm (Figure 1.2). Clark et al (1996a) suggest that the 
mandible should be protruded by 50-75% of maximum, and should only be 
opened enough for the construction of the device. The appliance was an 
acrylic maxillary and mandibular splint retained by wrought stainless steel 
clasps. Labial and lingual wire connectors were used and there was a 
breathing space between the anterior teeth.
The author’s wife reported that snoring was moderated to a level that did 
not disturb her sleep. However, there was pain in the temporomandibular 
joint upon awakening. This discomfort disappeared within an hour.
The author showed evidence of bruxism and he felt that the rigid material 
used in the design, which prevented any movement, contributed to the 
discomfort. Kobayashi et al (1984) suggested that bruxists had a 
significantly higher frequency of sleep apnoea.
It was felt that a more forward position might be more beneficial and a 
second appliance was constructed to a new registration. Luks et al (1996) 
suggested that a device that increases vertical dimension and protrudes the 
mandible may be more effective than one which modifies mandibular 
position in one dimension only. Although this appliance was successful, 
the appliance, with wrought wire retainers and labial wire connectors did 
require more time to construct.
The second appliance was constructed in a resilient polyvinyl acetate 
polyethylene (PVAc-PE), (Figures 2.1) which was transparent, 
physiologically harmless, insoluble in water, odour free and inactive 
(Erkoflex, E M Natt Ltd, London) and followed the design suggested by 
Jagger and Milward (1995) for the construction of a bimaxillary 
mouthguard used by sportsmen. This design was also similar to that 
described by Lyon et al (1992) for snoring and sleep apnoea.
The appliance was constructed in a more open protrusive position to 
ascertain whether this position would be of more benefit. The mandible 
was opened 7 mm in the inter-incisal region, with a forward position of 
approximately 75 per cent of maximum opening, (7 mm). The author 
reported no discomfort in this position. The appliance was constructed 
using a thermo-forming machine, (Drufomat, Dreve, Panadent, London) to 
provide upper and lower arch soft splints. The thickness of the blanks used 
was 4 mm. These splints covered all the maxillary and mandibular teeth 
and extended approximately 5 mm buccally, labially, and lingually to 
provide retention. The author had a full dentition.
The splints were finished and sealed together in the protrusive registration, 
on an articulator, using a heat gun with fusing pins, (Erkoflex 82, E M Natt 
Ltd, London). After forming, the thickness of the splint was about 2 mm 
but can be thinner depending on the shape and depth of the cast. This can 
result in thinning, particularly on the labial aspect of the splints. In order to 
compensate for thinning and provide a degree of rigidity for the anterior of 
the joined appliance the periphery of the upper and lower labial splints were 
restored to a thickness of 2 mm using the glue gun and fusing pins. This 
appliance proved to be successful in preventing snoring. The author’s wife 
reported that the subject did not snore with the appliance. The author 
occasionally experienced mild discomfort of the TMJ on awakening on 
some occasions. However, this discomfort did not last more that 20 
minutes.
The appliance with the Hyrax expansion screw (Figures 2.2, 2.3) was 
constructed using thermoformed disks in a combination of hard and soft 
material (Erkodent, E M Natt, London). This 3 mm material provided a 
hard outer shell with a softer inner material for comfort. This device was 
similar to the Kleerway appliance and allowed the jaws to be opened. An 
occlusal platform was incorporated in acrylic resin to allow the mandible to 
move in a more horizontal position if required. This appliance was also 
successful in reducing snoring but was not considered as effective as the 
softer type material and also required considerably more time to construct. 
The expansion screw and wires in the palate did not prove to be 
uncomfortable or restrict the tongue. Although this appliance allowed for 
mouth opening the author did not find it a significant advantage.
An alternative appliance was also tried by the author, this was an oral 
device called the Snorban. This consisted of a pre-formed, acrylic polymer 
blank which was softened in hot water and then moulded by the patient in 
their own mouth. This appliance was claimed by the manufacturer to be a 
mandibular positioning appliance. However, the author found it impossible 
to gain adequate retention for this appliance and found that the appliance 
could not be held in position without a conscious effort, which meant that it 
could not be worn during sleep.
Another prefabricated device, the Snorelezz, was used without success, as 
retention again proved difficult.
Figure 2.1 The semi-flexible mandibular advancement device (MAD).
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In an attempt to improve retention, soft lining material was added to the 
appliance but it did not adhere to the device and the design of the device 
was too shallow to provide adequate retention.
During the course of this study a new material (also PVAc-PE) was 
introduced which although was still flexible was more rigid than previously 
available (Erkoflex 95, E M Natt Ltd, London). An appliance using this 
material was also used. The material was preferred as it provided better 
retention and did not have to be extended as far towards the vestibular 
sulcus.
2.2 Protocol for Patient Evaluation of a Mandibular 
Positioning Appliance
The project protocol was approved by the Ethics Committee of Glasgow 
Dental Hospital and School NHS Trust (Appendix C). The team used in 
our study consisted of a Consultant Physician, a Consultant Prosthodontist, 
and an Instructor in Dental Technology. Patients were referred from the 
Sleep Breathing Disorders Clinic at Glasgow Royal Infirmary to be treated 
with the PVAc-PE bimaxillary device. Patients were categorised as either 
simple snorers or snorers who also had symptoms of mild to moderate 
OSA. Some of the OSA patients had tried nasal mask CPAP but had been 
unable to tolerate this form of treatment. Other treatments that had also 
been tried by some patients were ENT surgery, most often treatment for a 
deviated septum, drug therapy (Protriptyline) and weight loss.
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Figure 2.3 A Hyrax expansion screw rotated about 90° to produce an 
adjustable mandibular advancement device.
Figure 2.4 An intra-oral view with the Hyrax screw appliance allowing 
opening of the mandible.
All patients had undergone at least one limited sleep study. Sleep studies 
(mostly home based) comprised of assessment of respiratory variables that 
always included oronasal airflow and oxygen saturation monitoring. All 
traces were manually reviewed and graded accordingly into Normal (AHI< 
5 per hour), Borderline (AM 10-15 per hour and or RD I5-15 per hour), 
Possible OSAS (AM 15-20 per hour), Definite (AM >25 per hour). The 
apnoea and hypopnoea index, calculated over the monitoring period, and 
desaturation data were combined on visual analysis of the trace to produce 
a respiratory distress index (RDI). Patients also completed the Epworth 
Sleepiness Scale, which consists of eight questions that ask how likely one 
is to doze off or fall asleep in everyday situations.
Patients were then referred to the Dental Hospital for an oral appliance.
A letter (see Appendix C) was sent with the patient’s initial appointment 
asking that partners attended with the patient. On the initial visit to the 
Dental Hospital the nature of the study was explained to the patient and 
partner by the author and patients signed a formal consent form. An 
information sheet (see Appendix C) for patient and partner was also given 
at this interview. A questionnaire was given to the patients (A1, appendix 
C) and partner (B1 appendix C). Patients were asked if they were 
currently receiving dental treatment and if they had received treatment for 
TMJ problems.
There were three areas assessed by the questionnaires. Firstly, patient 
compliance with the device and its effect on their snoring as assessed by 
partners. Secondly, the effect on daytime sleepiness and the quality of 
sleep, again assessed by the partners, and thirdly, the effect on the partner’s 
sleep quality.
A decision was made as to whether the patient had sufficient teeth to be 
able to wear the appliance. Patients had varying backgrounds and dental 
states and there was no set minimum number of teeth required.
Impressions of upper and lower arches were taken, together with a 
protrusive jaw registration. The oral appliance was then constructed and 
fitted.
Patients received their appliance on the day of their first visit, although this 
was subsequently changed to receiving the appliance on the following day 
or two. The appliance was evaluated after 4 weeks by means of a second 
questionnaire for patient ( A2, Appendix C) and partner (B2, Appendix C). 
Patients were subsequently re-evaluated at the Sleep Clinic when wearing 
the intra-oral appliance.
2.3 Impressions and jaw relationship
Impressions were taken in alginate using disposable stock trays, to provide 
full impressions of all teeth and vestibular sulcus depth.
The protrusive jaw relationship was established by first ascertaining the 
maximum amount of protrusion and then establishing a comfortable 
forward position of 50 to 75% of maximum. Impression compound was 
used to fix the position and also determine the amount of opening between 
upper and lower arches. The amount of opening was determined by the 
clinician as the minimum required, allowing protrusion, to provide enough 
space to construct the appliance. The total opening was partly determined 
by the overbite of each patient. Aluminium impregnated wax was placed 
over the impression compound and pressed over the labial and buccal 
surfaces of the teeth.
2.4 A Simple Measuring Tool
To enable the jaw position to be ascertained a simple measuring tool was 
constructed. It consisted of two tubes of stainless steel, of 3-mm diameter, 
soldered together. A handle was added to one of the tubes so that the tubes 
were on top of each other. The tubes were used in conjunction with a 
stainless steel rod on the lower tube. This device enabled the clinician to 
check how much mandibular advancement had been achieved. The 
patient’s overjet was measured and then the patient was instructed to 
protrude their mandible as far forward as they could. This position was 
then measured to obtain the maximum protrusion (Figures 2.4).
2.5 Laboratory Construction Stages
Two sets of dental casts were produced from the impressions, one set on 
which the appliance was constructed and the other set mounted on an 
articulator in the protrusive position. Two sets of casts were required as the 
casts used in the thermoforming process were usually damaged during the 
finishing procedures.
1. The impressions were poured in dental stone. On setting, the 
impressions were carefully removed to avoid damage to the impressions 
and poured a second time. The first pour served as master casts that could 
be duplicated if modification to the appliance was necessary and new 
vacuum formed pieces were required. If the impressions could not be 
removed successfully then the casts were duplicated using reversible 
hydrocolloid.
2. The second pour served as the casts on which the appliance pieces were 
formed.
3. These casts were trimmed on a model trimmer to the required depth to 
ensure that when the appliance was formed the PVAc-PE blank would be 
of even thickness. This was important as failure to do this could result in 
thinning of the blank or failure to adequately form onto the cast. The 
amount that the formed piece extended into the sulcus depended on the 
number and arrangement of the teeth.
4. Disks of 4-mm PAVc-PE were heated for approximately two minutes 
and then vacuum formed (Drufomat, Panadent, London) onto the casts.
The casts had been given an application of a plaster-separating medium. A 
thickness of 4mm was preferred to allow a measure of rigidity without the 
need to include metal wires. After forming, the thickness over the casts 
was approximately 2mm.
5. Following thermoforming, the individual pieces were trimmed to the 
required sulcus depth and then fitted to the mounted casts. The labial 
border was thickened using a glue gun with fusing pins to give an even 
thickness where required. This depended on the retention that that would 
be provided by each piece. The splints covered all the maxillary and 
mandibular teeth.
6. The first pour casts were mounted on an articulator using the wax and 
compound registration. An articulator with an incisal post was used to 
maintain the registered position. The amount of opening and mandibular 
advancement was measured on the articulator by measuring from fixed 
parts in the intercuspal position to the registered protrusive position. The 
amount of opening was approximately 5 mm inter-incisally.
7. The upper and lower pieces were trimmed where necessary on the 
occlusal surface to leave a space of 2mm between the two splints for the 
joining material. The occlusal surfaces were left roughened to assist the 
joining of the fusing pins.
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8. The upper and lower pieces were joined with a heat gun (Figure 2.8) 
using fusing pins (Erkoflex 82 or Erkoflex 95, E M Natt Ltd, London).
The fusing pins were also PVAc-PE but were extruded from the gun in a 
viscous 3 mm thick rope. This was placed on the upper or lower piece and 
the articulator member closed while the material was soft. The glue gun 
also allowed edentulous areas to be easily filled.
The excess from the joined pieces was then finished using suitable 
trimmers for soft materials and polished using nylon disks (Lisko disk, E M 
Natt Ltd, London) ready for delivery to the patient. The finishing disks 
provided a smooth polished surface although a better finish can be achieved 
by flame polishing, either with a naked flame or with a dry air heat gun. 
However, care must be exercised that this process does not distort the 
appliance.
The upper and lower pieces were not joined anteriorly, which leaves a 
breathing space to allow patients to breathe through their mouth should 
their nasal passages be blocked. The laboratory time required to produce 
an appliance was approximately one hour and thirty minutes.
On delivery to the patient, appliances were adjusted for comfort and the 
patient was instructed in the handling and cleaning procedures. Patients 
were advised to clean the appliance each morning by rinsing in cold water 
and cleaning with a toothbrush.
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Subjects were also advised to keep their appliance stored in cold water 
when not in use and that this should be changed daily. It was also 
recommended that the appliance should be carefully cleaned using 
detergent once per week using cold or tepid water. At the appliance 
delivery the maximum protrusion was measured and checked against the 
amount of protrusion for the registration using the measuring tool.
Patients were advised that they might experience some muscle discomfort 
initially and that they would experience an increase in saliva production but 
that both of these problems should subside in time.
The mounted casts of the patients were stored and duplicated when 
required to fabricate new pieces for the device.
2.6 Randomised Patient Allocation
The number of patients who received an appliance was 105. There were 89 
men and 16 women with a mean age of 49 years (range 30-78 years).
The first 36 patients were randomly allocated into two groups with 18 
patients in each group. Group A comprised of 14 men and 4 women, with 
16 men and 2 women in group B. The patients and partners in A group 
were asked to complete pre-appliance questionnaires with the appliance 
being delivered that day. The subjects were reviewed after 4 weeks.
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The patients in B group were asked to complete the pre-appliance 
questionnaires but did not receive the appliance until a further 4 weeks.
At their second visit, patients in B group were asked to complete 
questionnaires A1 and B1 again. The B group acted as a control for the 
study, as no treatment was given for 4 weeks. The questionnaires were 
used to establish that no change had occurred in their symptoms and also to 
test the reliability of the VAS scores
2.6.1 Patient questionnaire
There were separate questionnaires for patients and their partner (see 
Appendix C). The patient questionnaire asked personal details, name, sex, 
age, date of birth, occupation and height and weight. The height and 
weight enabled a body mass index (BMI) to be calculated for each patient, 
as obesity is a principle risk factor in snoring and obstructive sleep apnoea.
As alcohol and smoking are also identified as risk factors, questions were 
asked about smoking (quantity per day), and alcohol consumption (units 
per week). As well as personal details and habits, volunteers were asked 
questions on their quality of sleep. These were the numbers of hours slept, 
whether they felt refreshed on waking, and if they felt sleepy during the 
day. After wearing the appliance for four weeks the patients were asked to 
complete a post-appliance questionnaire. Visual analogue scales to record 
responses were used.
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2.6.2 Partner Questionnaire
It was felt that the use of questionnaires must include a questionnaire for 
partners in addition to patients, to provide a subjective assessment of the 
effect of the appliance (Appendix C). Questions for partners included the 
level of the patient’s snoring, in addition to how refreshed the patient 
seemed, and if they complained of daytime sleepiness. Partners were also 
asked questions on the quality of their own sleep. Visual analogue scales 
were used for these questions also.
2.6.3 Visual Analogue Scale Questions
In the preparation of the visual analogue scale (VAS) it was important to 
chose end phrases that were readily understood and that best defined the 
extreme limits of the responses. In the patient pre-appliance questionnaire 
(Al), the anchors to the question relating to their snoring were “Does not 
snore at all” and “Extremely loud”. To the questions on whether they felt 
refreshed on wakening and if they felt sleepy during the day, the anchors 
were “Never” and “Always”. The anchors to the question on their quality 
of sleep were “Awful” and “Excellent”. In the post-appliance 
questionnaire (A2) on the question of comfort of the appliance, the anchors 
were; “Extremely comfortable” and “Totally uncomfortable”. On 
satisfaction with the appliance the anchors were: “Extremely dissatisfied” 
and “Totally satisfied. In the pre-appliance partner questionnaire (B1) to 
the question: How loud does your partner snore? the anchors were: “Does 
not snore at all” and “Extremely loud”.
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Figure 2.4 A Simple Measuring Tool.The patient’s overjet in the 
intercuspal position was recorded with the tool and then the patient was 
instructed to protrude their mandible to the maximum and this position was 
measured.
Figure 2.5 After thermoforming, the upper and lower pieces were trimmed 
and joined with fusing pins using a heat gun.
All the other questions had the anchors: “Never” and “Always”, with the 
exception of the question: How would you rate the quality of your sleep, 
the anchors were: “Awful” and “Excellent”.
2.7 Statistics
The possibility of bias towards each end of the scale in the data from the 
VAS scores leading to a deviation from a normal distribution was 
acknowledged and so the data were analysed using the Wilcoxon test for 
non-parametric scores (log transformation) before tests were applied. The 
transformed data from before and after fitting of the appliance were then 
subjected to paired t-tests to test for any significant difference. All tests 
were conducted at the 95% level of significance.
In addition to the VAS questions, there was the opportunity for the subjects 
and their partners to offer comments in pre-appliance and post appliance 
questionnaires.
2.8 Appliance Delivery
The appliances were constructed and delivered to the first group of patients 
on their first visit. The time taken to construct the appliance was 
approximately one hour thirty minutes. On delivery of the appliance the 
patients were shown insertion and removal. The majority of patients found 
it was best to insert the appliance on the upper arch and then bring their jaw 
forward and place their teeth in the lower part.
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While the appliance was newly in place instructions were given on care and 
maintenance of the appliance in addition to possible side effects that they 
might experience, such as excess salivation and minor muscle and tooth 
discomfort initially. The time taken allowed the patients to determine if 
there was any discomfort which required adjustment. When the patients 
were satisfied with the fit of the appliance and were able to insert and 
remove the appliance satisfactorily an appointment was made to see them 
in four weeks.
2.8.1 Four Week Review
At the 4-week review, patients and their partners completed the second 
questionnaires (A2, B2), (Appendix). The patients and partners were 
asked to complete the questionnaires before being interviewed to avoid any 
bias to their responses. In the first group of patients there were a small 
number who had limited success with the appliance and on evaluating their 
jaw position it was felt that they could be registered in a more forward 
position. The majority of patients who had this done reported an 
improvement at their next appointment one week later.
2.8.2 Follow-up
Patients and partner were asked to attend the Dental Hospital at 12-week 
intervals up to one year. If a partner could not attend a questionnaire was 
sent with a stamped addressed envelope. A telephone survey was 
conducted in September 1998 of 25 patients who had worn the appliance for 
at least one-year to ask if they were continuing to wear the appliance.
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CHAPTER 3 
RESULTS
From September 1996 to March 1999 one hundred and five patients (89 
male, 16 female) received the semi-flexible mandibular positioning 
appliance. The mean age was 49 years, (range 28-79), SD 10.7 with a 
mean body mass index (BMI) of 29 (range 20-46), SD 4.6.
After completing the four-week review, patients were seen at 12-week 
intervals up to 1 year (Table 1). A telephone survey was conducted in 
September 1998 at which time a possible 54 patients could have reached 
one year. The actual number who completed all reviews was 29. Patients 
and partners were asked to attend for reviews but some partners did not 
attend and questionnaires were given to patients with a stamped addressed 
envelope to be returned (Table A l, see Appendix A). Twelve patients did 
not have a partner. Results are presented up to 1-year review.
Number of 
weeks
Patient 
Actual Possible
%
Actual
Partner
Possible
%
4 93 105 89 76 83 91
16 53 89 59 42 79 53
28 36 72 50 30 62 48
40 31 66 47 23 56 41
52 29 59 49 25 51 49
104 26 13 50
Table 1. The actual and possible number of patients and partners who 
attended review at 4 weeks and completed questionnaires at 12 week 
interval follow-up to 2 years.
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A two-year follow-up was conducted by a telephone survey asking patients 
if they were still using the appliance (Table 1). Partners who did not 
complete a 4-week review were not included in the baseline figures.
3.1 Control group
The responses to all the questions given to the contol group, i.e. patients 
and partners who completed 2 baseline assessments 4 weeks apart (n=14), 
were very consistent, with no significant difference between the two sets of 
data (P = 0.46).
3.2 Review at 4-Weeks
Twelve patients (11 %) did not return for the 4 week review (Table 2). An 
attempt was made to contact these patients by telephone. One patient 
discontinued with the appliance because he found the appliance 
“unsightly”, one stated that the appliance was uncomfortable to wear but 
did not return to have adjustments despite appointments being made, and 
four failed to respond to letters or reminders to attend their review 
appointments. Of these four, two were contacted by telephone but failed 
to attend and two could not be contacted by telephone. One patient 
contacted had been diagnosed as being depressed and did not wish to 
continue with the study.
Of the remaining 93 patients who completed the 4 week review, 81 (87%) 
were male and 12 (13%) female (Table 3). Twelve patients did not have a 
partner. Patients who could not wear the appliance at this review were 
referred back to the sleep clinic.
Patient Telephone New
appointment
Reminder
letter
Comment
90 no yes yes failed to attend
50 yes yes yes excess saliva made it difficult to wear
36 no yes yes failed to attend
76 yes yes (2) yes failed to attend - wearing appliance
27 yes yes yes failed to attend - wearing appliance
92 no yes (2) yes failed to attend
46 discontinued - appliance “unsightly”
43 yes yes yes appliance needed adjustment
67 yes yes (2) yes failed to attend - wearing appliance
3 no yes yes failed to attend
62 yes yes yes failed to attend - wearing appliance
47 yes discontinued - depression
Table 2 The 12 patients who failed to complete 4-week review
Number of patients who completed questionnaire 93
Number of partners who completed questionnaire 76
Number of patients who did notcompleted questionnaire 6
Number of patients without partner 12
Table 3 The number of completed questionnaires at the 4-week review.
3.3 16-Week Review
At the next review at sixteen weeks, 53 patients out of a possible 89 (59%) 
attended (Table 4).
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Number of patients completed questionnaire 
Number of partners completed questionnaire 
Number of partners who did not complete questionnaire 
Number of patients without partner 7
42
4
53
Table 4. The number of completed questionnaires at the 16- week review.
Reasons for not continuing after the 4-week review were (Table A2, see 
Appendix A).
• 6 complained of hypersalivation
• 1 had surgery and achieved substantial weight loss
• 1 was hospitalised with a heart attack
• 1 found the appliance made no difference
• 1 preferred CPAP
• 1 no longer had a partner
• 1 experienced painful teeth
• 2 found the appliance uncomfortable to wear
• 8 did not return for review
3.4 28-Week Review
Thirty-six out of a possible sixty-two patients (58%) completed the 28- 
week review (Table 5). Reasons from the patients who discontinued at 
this stage included one patient who had separated from his/her partner and 
did not feel the need to continue with the appliance and five who were lost 
to follow-up.
Number of patients completed 36
Number of partners completed 30
Number of partners who did not complete 2
Number of patients without partner 4
Table 5. The number of returned questionnaires at the 28-week review.
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3.5 40-Week Review
Thirty-one patients from a possible 66 (47%) completed questionnaires at 
40-weeks (Table 6). There were five patients lost to follow-up at this 
stage.
Number of patients completed questionnaire 31
Number of partners completed questionnaire 23
Number of partners who did not complete questionnaire 3
Number of patients without partner 3
Table 6. The number of completed questionnaires at the 40-week review.
3.6 52-Week Review
The number of patients who wore the appliance during the study period for 
52 weeks was 29 from a possible total of 59 (49%), (Table 7).
Number of patients completed questionnaires 29
Number of partners completed questionnaires 25
Number of partners who did not complete questionnaires 1
Number of patients without partner 4
Table 7. The number of completed questionnaires at the 52-week review.
3.7 Number of Teeth
The mean number of teeth in both arches was 22.3, SD 4.2 with the mean 
number of upper teeth 10.8, SD 2.7 and the mean number of lower teeth
11.5, SD 2.1.
The lowest number of teeth in the upper arch was four, and in the lower 
arch was five. No patient was excluded from the study due to lack of 
teeth.
3.8 Mandibular Position
In 93 of the patients the amount of mandibular advancement varied from 1 
to 12 millimetres (Figure 3.1) with a mean of 6.2 mm, SD 1.9. In a 
number of patients (38) the device to measure maximum protrusion was 
used. There were 6 patients (16%) who were less than 50 % of their 
maximum protrusion, 24 (63%) who were between 50% to 75% of 
maximum and 8 (21%) who were at greater than 75 % of their maximum.
Ten patients from the first thirty-six reported that the appliance had made 
little or no difference. It was felt that in each case the mandible could be 
moved further forward and so another registration was taken and these 
patients were reassessed after two weeks. Of this group five reported an 
improvement.
The amount of opening of the jaw varied between 3 mm and 13 mm when 
measured on the casts on the articulator (Figure 3.2). The mean opening 
was 7 mm, SD 2.3 (N = 93) with a mean inter-incisal opening of 4 mm, SD
2.0. The amount of opening varied between patients depending on the 
amount of overbite and the arrangement of tilted or over-erupted posterior 
teeth, which in some patients precluded a more closed protrusive position.
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3.9 The Use of a Control for the Visual Analogue Scales
In the patients who were randomly allocated to a control group, there was 
no significant difference in their responses to the questionnaires at the 
beginning and the end of the 4-week “waiting time” (P = 0.46, paired t- 
test).
3.10 Patient Responses to Questionnaires
3.10.1 Number of Days Appliance Worn
At the 4 week review of 93 patients the mean number of days the appliance 
was worn was 5.7, SD 1.8. At 16 weeks from 53 patients the mean was 
5.6, SD 1.9; 28 weeks (36 patients) was 5.2, SD 2.2; at 40 weeks from (31 
patients) was 5.1, SD 2.1 and at 52 weeks (29 patients) was 5.5, SD 2.0.
(See Table 8).
4 week 16 week 28 week 40 week 52 week
Number of days appliance 5.7 5.6 5.4 5.1 5.5
worn (n=93) (n=53) (n=36) (n=31) (n=29)
Table 8. The mean number of days the appliance was worn.
3.10.2 Comfort of Appliance
The mean VAS scores for comfort were 6.5, SD 2.5 at 4 weeks, 7.0, SD,
2.1 at 16 weeks, 7.2, SD 2.3 at 28 weeks, 7.3, SD 2.6 at 40 weeks and 7.5,
SD 1.9 at 52 weeks (Table 9). The mean number increased the longer the 
appliance was worn as individuals who found the appliance uncomfortable 
to wear dropped out.
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Figure 3.1 The mandibular advancement was measured on the mounted 
casts and compared with the maximum protrusion.
Figure 3.2 The amount o f opening was also measured from the mounted 
casts, together with the inter-incisal opening.
2637343873
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_______________ 4 week 16 week 28 week 40 week 52 week
Comfort of 6.5 7.0 7.2 7.3 7.5
appliance (n=93) (n=53) (n=36) (n=31) (n=29)
Table 9. The patient’s response to how comfortable the appliance was to 
wear.
3.10.3 Patient Satisfaction
Patient satisfaction for the appliance maintained a mean of between 7 and 8 
from the VAS scores. This level was maintained throughout the 52-week 
period, which included appliance replacements when they were becoming 
less effective through wear. From interview at review stages it was clear 
that the fact that the device had to be worn each night also affected patient 
satisfaction. The mean VAS scores for satisfaction were, 7.2, SD 2.4 at 4 
weeks, 8.1, SD 1.8 at 16 weeks, 7.9, SD 1.8 at 28 weeks, 7.6, SD 2.4 at 40 
weeks and 7.9, SD 2.0 at 52 weeks (Table 10).
_______________ 4 week 16 week 28 week 40 week 52 week
Satisfaction 7.1 8.1 7.9 7.6 7.9
with appliance (n=92) (n=53) (n=36) (n=31) (n=29)
Table 10. The patients’ response to how satisfied they were with the 
appliance. One patient did not complete this question.
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3.10.4 State of Patient Refreshment Upon Wakening
Patients were asked how refreshed they felt on wakening. Before wearing 
the appliance the mean was 3.5, SD 2.4. At the 4 week review the mean 
was 5.9, SD 2.5 (Figure 3.3). These figures increased to 6.7, SD 2.4 at 16 
weeks, 7.0, SD 2.3 at 28 weeks, 6.5, SD 2.9 at 40 weeks and 7.0, SD 2.1 at 
52 weeks (Table 11). The differences between baseline and each review 
were statistically significant (Table 11).
baseline 4 week 16 week 28 week 40 week 52 week
Refreshed on 3.4 5.9 6.7 7.0 6.5 7.0
wakening (n=93) (n=93) (n=53) (n=36) (n=31) (n=29)
p = 0.001 p = 0.001 p = 0.001 p = 0.001 p = 0.001
Table 11. How refreshed patients felt on wakening.
3.10.5 Daytime Sleepiness
Patients reported that daytime sleepiness had reduced from a mean of 6.1,
SD 2.6 at baseline to 3.8, SD 2.4 after wearing the device for 4 weeks 
(Figure 3.4). The mean scores were further reduced at subsequent reviews 
to 2.6, SD 2.1 at 16 weeks, 3.9, SD 2.9 at 28 weeks, 3.4, SD 2.5 at 40 
weeks and 3.1, SD 2.5 at 52 weeks (Table 12). The differences between 
baseline and each review were statistically significant (Table 12).
baseline 4 week 16 week 28 week 40 week 52 week
Patient daytime 6.1 3.8 3.7 2.5 3.9 3.1
sleepiness (n=93) (n=93) (n=53) (n=36) (n=31) (n=29)
p = 0.001 p = 0.001 p = 0.001 p = 0.001 p = 0.001
Table 12. The VAS scores of the level of patient daytime sleepiness.
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3.10.6 Quality of Sleep
Patients reported that their perceived quality of sleep had improved from a 
mean of 3.5, SD 2.2 at baseline before wearing the appliance to 6.3, SD 2.2 
after wearing the appliance for 4 weeks (Table 13), (Figure 3.7). The 
differences between baseline and each review were statistically significant 
(Table 13).
baseline 4 week 16 week 28 week 40 week 52 week
Patient quality 3.5 6.3 7.0 7.3 7.1 7.4
of sleep (n=88) (n=93) (n=53) (n=36) (n=31) (n=29)
p = 0.001 p = 0.001 p = 0.001 p = 0.001 p = 0.001
Table 13. The mean VAS scores of the patient perception of quality of 
sleep.
3.11 Partner Responses to Questionnaires
3.11.1 Partner Assessment of Difference Made by Appliance
In response to question C (Questionnaire B2, see Appendix); did the 
appliance make a difference to your partners snoring? The mean score at 4 
weeks was 6.8, SD 2.8, at 16 weeks this had increased to 7.4, SD 2.1, 28 
weeks 7.9, SD 1.7, 40 weeks 7.5, SD 2.6 and 52 weeks to 7.4, SD 2.2 
(Table 14).
102
10 
9 
8 
7'
6 
5 
4'
3 
2 
1- 
0
Baseline 4 week
Figure 3.3 Patient respose to how refreshed they felt on wakening before 
wearing the appliance and after a 4-week period of use. Mean before 
wearing the device was 3.4, SD 2.4 and after 5.9, SD 2.5 (n = 93).
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Figure 3.4 Patient response to their perceived level of daytime sleepiness before 
and after a 4-week period of wear with the appliance. The mean before use was
6.1, SD 2.6 (10 cm VAS) which reduced to 3.8, SD 2.4 (n = 93).
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_________________ 4 week 16 week 28 week 40 week 52 week
Difference made 6.8 7.4 7.9 7.5 7.4
by appliance (n=76) (n=42) (n=30) (n=23) (n=25)
Table 14. The mean values from the partner VAS scores of the difference 
made by the appliance to patients snoring.
3.11.2 Partner Assessment of Snoring Reduction
The perception of partners to the patients level of snoring was reduced 
from a mean value of 8.5, SD 1.5 at baseline to 3.2, SD 2.7 at the 4-week 
review (Figure 3.5). At 16 weeks the mean score was 2.5, SD 2.0, at 28 
weeks 2.3, SD 1.8, at 40 weeks 2.5, SD 2.4 and at 52 weeks 3.4, SD 2.4 
(Table 14). There was a significant difference between baseline and each 
review, p = 0.001 (Table 15).
___________ baseline 4 week 16 week 28 week 40 week 52 week
Partner 8.5 3.2 2.5 2.3 2.5 3.4
perception (n=76) (n=76) (n=42) (n=30) (n=23) (n=25)
of snoring
p = 0.001 p = 0.001 p = 0.001 p = 0.001 p = 0.001
Table 15. The mean VAS scores of the partner perception of the patient’s
level of snoring.
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3.11.3 Partner Perception of Level of Patient’s Refreshment on 
Wakening.
Partners were asked if they thought that the patient seemed more refreshed 
on wakening after using the appliance. The mean score increased from 
2.9, SD 2.6 at baseline to 6.2, SD 2.7 at 4 weeks (Figure 3.6) and increased 
beyond this figure at subsequent reviews to 7.1, SD 2.1 at 16 weeks, 6.9,
SD 2.4 at 28 weeks, 6.2, SD 3.2 at 40 weeks and 6.6, SD 2.6 at 52 weeks 
(Table 16). There was a significant difference between values at baseline 
and at each review, p = 0.001, (paired t-test) (Table 16).
_________________ baseline 4 week 16 week 28 week 40 week
Partner perception 2.9 6.2 7.1 6.9 6.2
of how refreshed (n=76) (n=76) (n=42) (n=30) (n=23)
patient seemed
on wakening p = 0.001 p = 0.001 p = 0.001 p = 0.001
Table 16. The mean VAS scores of the patient perception of how 
refreshed their partner seemed on wakening.
3.11.4 Partner Perception of Patient’s Daytime Sleepiness
Partners were also asked their perception of the level of daytime sleepiness 
of the patient. The mean score at baseline was 7.2, SD 2.7, which was 
reduced to a mean score of 3.4, SD 2.3 at the 4-week review. At 16 weeks 
the score was 2.3, SD 2.2, at 28 weeks 2.7, SD 2.5, at 40 weeks 3.2, SD 3.0 
and at 52 weeks 2.9, SD 2.4 (Table 17). There was a significant difference 
between values at baseline and at each review, p = 0.001, (paired t-test) 
(Table 17).
52 week 
6.6
(n=25)
p = 0.001
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baseline 4 week 16 week 28 week 40 week 52 week
Partner perception 7.2 3.4 2.3 2.7 3.2 2.9
of level of patient (n=76) (n=76) (n=42) (n=30) (n=23) (n=25)
daytime sleepiness
p = 0.001 p = 0.001 p = 0.001 p = 0.001 p = 0.001
Table 17. The mean values from the VAS scores of partner perception of 
the level of daytime sleepiness of their partner.
3.11.5 Irritability on Wakening
In addition to the partner perception of patient refreshment on wakening, 
partners were asked to score the level of patients irritability on wakening as 
an indication of the quality of sleep of the patient. The mean score was
4.5, SD 3.1 at baseline, which reduced to 2.6, SD 2.8 at the 4-week review.
The mean scores at subsequent reviews were: at 16 weeks 1.8, SD 1.7, 28 
week 2.2, SD 2.2, 40 weeks 2.2, SD 2.3 and at 52 weeks 2.6, SD 2.6. A 
paired t-test was conducted at each review against the baseline score which 
showed that at 4 week, 16 week, 28 week and 52 week there was a 
significant difference (p < 0.05) but that at 40 week there was no 
significant difference (p >0.05), (Table 18).
baseline 4 week 16 week 28 week 40 week 52 week
27
(n=25) 
p = 0.04
Table 18. The mean values from the VAS scores of partner perception of 
patient irritability on wakening.
Partner perception of 4.5 2.6 1.8 2.2 2.2
how irritable their (n=76) (n=76) (n=42) (n=30) (n=23)
partner was
on wakening p = 0.001 p = 0.001 p = 0.004 p = 0.07
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Figure 3.5 The partner response to the level of snoring before and after a 4-week 
period of use with the appliance. The mean before was 8.5, SD 1.5 (10 cm 
VAS) which reduced to 3.2, SD 2.7 (n = 76).
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Figure 3.6 Partner perception of how refreshed patients were on wakening 
before and after a 4 week period of use with the appliance. The mean 
before was 2.9, SD 2.7 (10 cm VAS) which increased to 6.2, SD 3.2 
(n = 76).
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3.11.6 Tired on Wakening
As it was the sleep of the partner that was disturbed by the level of snoring, 
partners were asked on how tired they felt on wakening before and after the 
patient had worn the appliance. The mean VAS score at the baseline 
interview was 6.6, SD 2.7 which reduced to 3.4 SD 2.7 at the 4 week 
review and at subsequent reviews at 16 weeks to 2.9, SD 2.8, 28 weeks to
2.2, SD 2.0, 40 weeks to 2.7, SD 2.9 and 52 weeks to 2.5, SD 2.1 (Table 
19).
There was a significant difference, P = 0.001, (paired t-test), (Table 19).
baseline 4 week 16 week 28 week 40 week 52 week
Partner response 6.6 3.4 2.9 2.2 2.7 2.5
to tiredness on (n=76) (n=76) (n=42) (n=30) (n=23) (n=25)
wakening
p = 0.001 p = 0.001 p = 0.001 p = 0.001 p = o.ooi
Table 19. The mean values from the VAS scores of partner perception of 
their tiredness on wakening.
3.11.7 Partner’s Quality of Sleep
Partners reported that their own sleep quality had improved after the 
subjects wore the appliance, with a mean score at baseline of 3.0, SD 2.0 
before which increased to 6.4, SD 2.5 (Figure 3.8) at the 4 week review 
which continued at subsequent reviews at 16 weeks of 6.9, SD 2.4, 28 
weeks of 7.5, SD 1.9, 40 weeks of 7.0, SD 3.0 and 7.3, SD 2.0 at 52 weeks 
(Table 20). There was a significant difference between baseline values and 
those at each review, P = 0.001 (Table 20).
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baseline 4 week 16 week 28 week 40 week 52 week
Partner response 3.0 6.4 6.9 7.5 7.0 7.3
to their quality o f  (n=76) (n=76) (n=42) (n=30) (n=23) (n=25)
sleep
p = 0.001 p = 0.001 p = 0.001 p = 0.001 p = 0.001
Table 20. The mean values from the VAS scores of partner response of 
their quality of sleep.
3.11.8 Partner’s Sleep Disruption Per Night
Partners were asked the number of times each night that the patients 
snoring disturbed them. The mean number at baseline was 5.1, SD 2.9, 
which reduced to 1.5, SD 1.8.
There was a significant difference between basline values and those at each 
review, P = 0.001 (Table 21).
baseline 4 week 16 week 28 week 40 week 52 week
Partner response 5.1 1.5 1.3 1.3 1.4 1.3
num ber o f  tim es per
night their sleep was (n=76) (n=76) (n=42) (n=30) (n=23) (n=25)
disturbed
p = 0.001 p = 0.001 p = 0.001 p = 0.001 p = 0.001
Table 21. The mean values from the VAS scores of partner response to 
number of times each night that their sleep was disturbed.
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3.12 Replacement appliances
Two patients had teeth extracted and one patient had two new crowns that 
necessitated making new appliances. Two patients accidentally damaged 
their appliance with immersion in hot water and one patient in attempted 
self adjustments which resulted in the appliance not fitting. In three cases 
the patient’s pet dog had chewed the appliance and in one case the 
appliance had been left behind while on holiday (Table A3, Appendix A).
Replacement of the appliance consisted of separating the two halves with a 
scalpel and replacing the defective half. Appliances needed to be replaced 
mostly between 28 and 40 weeks, although some patients continue to wear 
their original appliance for more than two years (Table A3, Appendix A).
3.13 Sleep Studies
All the patients in the study had reported socially disruptive snoring, with a 
number also reporting symptoms suggestive of sleep disordered breathing. 
Some patients had been attending the sleep clinic for more than two years 
and had undergone a series of treatments. The data presented is from 50 
patients who were fitted with the intra-oral appliance during a 24-month 
period from September 1996. However, there were 7 who did not have a 
partner and so the data is presented for 43 patients, 34 males and 9 females 
(mean age 48 years, range 31 -67 years) who did have regular sleep 
partners. Paired sleep studies are available for 33 patients (Table A4, 
Appendix A).
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Baseline 4 week
Figure 3.7 Patient perception of their quality of sleep before and after a 4- 
week period of use with the appliance. The mean before was 3.5, SD 2.2 
(10 cm VAS) which increased to 6.3, SD 2.2 (n = 93).
Baseline 4 week
Figure 3.8 Partner perception of their own quality of sleep before and after 
their partners wore the appliance for 4 weeks. Mean before use was 3.0, 
SD 2.0 (10 cm VAS) which increased to 6.4, SD 2.5 (n = 76).
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Chapter 4 
DISCUSSION
For the purposes of statistical analysis the patients who did not return for 
the 4-week review were counted as failures. It is possible that if the device 
was successful, there are some patients who would not bother to return for 
review simply because their problem has been solved. Also, there are 
some patients who are not prepared to wear the device each night, even 
though it may successfully eliminate the snoring, and therefore they do not 
return for review.
The number of days per week that the appliance was worn tended to 
decrease at each subsequent review. Patients settled into a pattern that 
suited their individual needs. For some patients snoring increased on nights 
when they consumed alcohol and so the device tended to be used more at 
the weekend when they were more likely to take alcohol. Shift workers 
would not use the appliance if they were not sleeping with their partners. 
Two patients who had OSA returned to using their CPAP machine after the 
initial 4-week period and only used the appliance when travelling because 
it was convenient and portable. Although the appliance reduced snoring 
for both patients, they did not feel as refreshed as with CPAP.
The number of patients lost to follow-up increased at each review period, 
as might be expected.
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Follow-up by the sleep clinic indicated that a few patients had discontinued 
using the device because of discomfort to their teeth or facial muscles. 
Other patients reported at the sleep clinic that they continued to use the 
device but simply did not return to the Dental Hospital for review.
Retention of the appliance varied between patients depending on the 
number, shape and position of teeth. Retention of the appliance was good 
even in situations were there were only a few teeth present. Patients 
presenting with bounded edentulous spaces often had better retention. 
Retention was less in individuals where there were bilateral or unilateral 
distal extension edentulous areas, particularly where there was good 
retention in the opposing arch. Patients with no teeth missing sometimes 
also presented problems with retention because of short crown height. The 
appropriate extension of the device varied depending on the number and 
arrangement of the teeth and on the amount of opening and protrusion of 
the mandible. From the summer of 1998 a more rigid flexible material 
became available (Erkoflex 95, E M Natt Ltd, England) and this was 
subsequently used in less retentive situations.
During the period of the study there were only three patients who reported 
TMJ discomfort. One patient reported discomfort after two weeks and two 
patients after four weeks. In each case the jaw relationship was checked 
and re-recorded if necessary. The casts were then split and re-joined as 
previously described.
113
In each case the patient reported that the discomfort did not re-occur.
The appliance was well tolerated by the majority of patients. Minor 
adjustments were made to improve comfort for a few patients. Side effects 
included uncomfortable teeth, uncomfortable jaw muscles and excessive 
salivation, particularly in the first two weeks. Although some patients did 
find the appliance uncomfortable to wear, particularly with hypersalivation, 
they were prepared to tolerate this discomfort.
The criteria for measuring success were by the subjective reports of patients 
and their partners, mostly by means of VAS scores. Patients who found 
that the appliance had reduced their snoring but was not comfortable to 
wear produced a low score in terms, of satisfaction. However, it was clear 
that this appliance has been effective in reducing snoring across a broad 
range of subjects. The reduction in satisfaction recorded at 52 weeks may 
be explained by the fact that more appliances needed to be replaced at this 
stage because of reduced retention.
Patients who used the appliance reported that they felt more refreshed on 
wakening and less tired during the day, probably because there was less 
restriction in the upper airway. Partners also reported that they were less 
tired and had a better quality of sleep, for obvious reasons. Couples 
reported that their relationships had improved because of the fact that they 
were no longer being wakened during the night and did not have to resort to 
moving to another room to get some sleep.
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Patients and partners who had previously been reluctant to stay with friends 
or invite friends to stay were now able to do so. More than one patient 
reported that the appliance had changed their life, that they could 
concentrate better, their performance at work had improved and they were 
less tired and had more energy during the day.
The use of mandibular advancement devices has been shown in previous 
studies to provide an alternative to existing forms of treatment for snoring 
and sleep apnoea.
This study has shown that a simple, one piece, non-adjustable mandibular 
advancement device can be used successfully in managing snoring and 
mild to moderate obstructive sleep apnoea. This study has also shown that 
there is no prerequisite for number of teeth or type of jaw relationship 
required and that is is suitable for a broad range of patients. As shown in 
other studies, the device was successsful in patients who could not tolerate 
nasal CPAP or who had no success with other treatments.
Appliances were replaced when patients said that it was no longer effective 
because either one or both parts lacked retention. Appliances were also 
replaced if patients had teeth extracted or other dental work done. The 
longevity of the appliance depended to some extent on the care taken of the 
appliance and the patient’s dentition.
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Although the mandibular advancement device was successful in reducing 
or eliminating snoring in 90 out of 93 (96.7%) patients, half the patients in 
the study were not wearing the device at one year. When offering this 
treatment to patients it is important to inform them that they have to wear 
the appliance each night for it to work and this means a possible lifetime of 
use.
There were patients and partners who reported subjective success but 
follow-up sleep studies showed that their results were worse with the 
appliance. Although not all follow-up sleep studies have been completed 
at this time, out of 33 patients who had follow-up sleep studies there were 3 
(9%) whose symptoms became worse. This may be because of the 
downward rotation of the mandible which occurs when the device is in 
place or it may be due to a natural progression of their OSA.
The question of whether a dentist should provide these appliances for 
patients with primary snoring without sleep clinic diagnosis needs to be 
addressed. In view of the finding of worsening of sleep study variables in 
a small number of patients, it would seem unwise for dentists to do so. 
Dentist would at least need to understand the problem of OSA, be aware of 
the significance of daytime sleepiness and be aware of the possibility of 
worsening OSA. Overnight pulse oximetry is the minumum investigation 
that should be performed to exclude OSA.
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The question of what constitutes success is important, as no recording of 
the noise level of snoring was conducted in this study. The subjective 
response of the partner was considered appropriate because if the partner is 
happy then that is really all that matters, the objective recording of noise 
level seems superfluous.
The type of appliance used in this study would appear to be a good first 
choice in the treatment of primary snoring and also snoring with mild OSA. 
The appliance has the advantage of being quick and inexpensive to make in 
the laboratory, is well-accepted, effective and remains effective for at least 
9-12 months. It is very cheap to re-make if necessary. However, this type 
of one-piece appliance may not be suitable for some patients and these 
might benefit from an adjustable device of the type which permits mouth 
opening.
The number of patients who have been referred from the sleep clinic 
continues to increase, as data shows that for a substantial number of 
patients, especially those with primary snoring, this therapy is successful. 
Those patients with mild to moderately severe OSA who cannot tolerate 
CPAP may also prefer dental appliance therapy.
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Chapter 5 
CONCLUSIONS
•  This mandibular advancement device is successful in the control of 
snoring and OSA and should be considered as the treatment of choice 
for primary snoring.
•  A minimum of four teeth in each arch are required for treatment success 
with an intra-oral appliance for snoring and OSA
• This mandibular advancement device should be effective for at least 
nine months before requiring replacement.
• Patients who could not tolerate CPAP were able to use the mandibular 
advancement device.
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4 week 16 week 28 week 40 week 52 week 
Patient B R Pt Pr Pt Pr Pt Pr Pt Pr Pt Pr
1. it it it it it * it it it it
2. * it it it it it * * it it it it
3.
4. it it it ir it it it * it it it
5. it it it
6. it it it it
7. it it
8. it k it it it * it it it k
9. it k it * it it * * k it it *
10. it * it it * * it *
11. it * it it it it * * * it it it
12. it it * it it
13. it
14. it it
15. it * it it
16. it it it it it it
17. it it it *
18. it it it it it it it it
19. it it it it it it it it
20. it it it it it it it it it k
21. it it it it it it it it it
22. it it it it it it it it it it k k
23. it it
24. it it ir it it it it k
25. it it
26. it it ' it it it it it it k
27.
28. it *
29. it
30. * it it it it it it it it it it it
31. ★ it it it it it
32. it it it it it it it it it k
33. it it it it
34. it it it it it it it ★ it k it it
35. it it it * * it it *
36.
37. it it it * it it it it it k
38. it k it * it it it it k
39. it
40. it
41. ★ it
42. * it it it it it it it it k
43.
44. it it it it it it it it it k
45. it it it it it
46.
47.
48. it it * it it it it it k
49. it it it it it it it it it k
50.
51. it it it it it it it k
52. it it k it it
Table A l. Completed questionnaires from patients and partners in 
chronological order 1-52. B = Baseline, R = Repeat baseline, Pt = patient, 
Pr = partner. Patients in bold type did not have a partner.
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4 week 16 week 28 week 40 week 52 week 
Patient Pt Pr Pt Pr Pt Pr Pt Pr Pt Pr
53. * * *
54. ★ * ★ it it * * * it *
55. * * ♦ *
56. * *
57. * it
58. * *
59. * * * * * * * * * *
60. * * * *
61. * *
62.
63. *
64. *
65. * * * ♦ * * * *
66. * * it *
67.
68. * + ♦ * *
69. * * * * * *
70. * ♦ * * * *
71. * * * *
72. * * * * * +
73. * *
74. * * * *
75. * * * *
76.
77. * *
78. *
79. * * ♦ *
80. *
81. * * *
82. * * * *
83. * * * +
84. * * * *
85. * *
86. * * * *
87. * ★ * *
88. * * * *
89. * * * *
90.
91. * *
92.
93. * *
94. it
95. *
96. *
97. *
98. * *
99. * *
100. * *
101. * *
102. * *
103. * *
104. * *
105. * *
Table A1 (continued). Patient 53-105. The 105 patients (partners) 
completed review questionnaires. B = Baseline, R = Repeat baseline, 
Pt = patient, Pr = partner. Patients in bold type did not have a partner.
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Patient Reason for non-continuance
6 Could not tolerate appliance- hypersalivation
7 Could not tolerate appliance- hypersalivation
13 Could not tolerate appliance- hypersalivation
15 Discontinued - ENT operation and weight loss
23 Appliance made no difference
25 Hospitalised - heart attack
28 Failed to attend - good response at 4 week
29 No partner
33 Could not tolerate appliance- hypersalivation
39 Failed to attend - good response at 4 week
40 Could not tolerate appliance- hypersalivation
41 Failed to attend - good response at 4 week
56 Discontinued - appliance “a nuisance” to wear
58 Discomfort due to pressure on teeth
61 Preferred CPAP
63 Failed to attend - good response at 4 week
64 Appliance uncomfortable to wear
73 Failed to attend - good response at 4 week
77 Failed to attend - good response at 4 week
80 Could not tolerate appliance- hypersalivation
85 Failed to attend - good response at 4 week
89 Failed to attend - good response at 4 week
Table A2. Reasons for not continuing after 4-week review
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Patient Time
in
weeks
Upper Lower New
appliance.
Comment
1 36 1 Loose
4 8
36
95
1
1
1
Loose
Loose
Loose
9 40
52
1
1
Loose
Loose
10 36 1 Loose
11 24
48
1
1
Dental treatment, teeth
extracted
Loose
17 36 1 Appliance lost
21 64 1 Dental treatment, new 
crowns
24 26
38
87
1
1
1
Loose
Loose
Dental treatment, teeth 
extracted
30 100 1 Loose
31 80 1 Loose
32 59 Patient damage 
(boiling water)
34 6
36
1
1
Dog chewed appliance 
Patient damage (self 
adjustment)
37 63 1 Loose
38 30
64
79
1
1
1
Loose
Loose
Loose
42 92 1 Loose
44 80 1 Loose
48 76 1 Patient damage 
( boiling water)
55 8 1 Loose
59 42 1 Dog chewed appliance
71 8 1 Dog chewed 
appliance
Table A3. The frequency of replacement appliances.
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Name Age Sex Other
reported
symptoms
Ep worth 
Score= >10
Previous
Therapy
Sleep
Study
1
Sleep
Study
2
Change
1. 65 F Y Negative -
2. 45 F Y B N Improved
3. 50 12 CPAP trial B - -
4. 41 P N Improved
5. 46 P D Worsened
6. 61 Y 15 D D Static
7. 63 P N Improved
8. 59 N N Static
9. 50 U3P/CPAP N N Static
10. 55 10 - N Static
11. 41 F 13 CPAP/Oxygen D - -
12. 30 F 18 P N Improved
13. 47 B N Improved
14. 45 Y 24 CPAP Trial B P Worsened
15. 49 D N Improved
16. 55 10 CPAP Trial N N Static
17. 50 Y 14 ENT/CP AP P P Static
18. 39 F 12 ENT/CPAP B B Static
19. 40 N N Static
20. 36 16 N N Static
21. 47 Y 11 D P Improved
22. 60 22 - - -
23. 45 17 N N Static
24. 47 P - -
25. 42 B N Improved
26. 52 12 N - -
27. 39 Y 11 N N Static
28. 57 Y 21 ENT/CP AP P B Improved
29. 48 B N Improved
30. 43 Y CPAP P - -
31. 43 ENT P D Worsened
32. 49 F Y 14 N N Static
33. 30 F 13 B - -
34. 46 CPAP Trial D P Improved
35. 43 F Y 11 CPAP D P Improved
36. 45 F B B Static
37. 61 12 CPAP Trial B - -
38. 47 Y 16 CPAP Trial B N Improved
39. 53 12 N N Static
40. 46 10 N N Static
41 33 Y 15 CPAP N - -
42. 33 10 ENT B N Improved
43. 67 ENT B N Improved
Table A4. Patient characteristics and sleep study profiles. ENT - 
procedures other than U3P, usually correction of deviated nasal septum. 
CPAP Trial - short home trial (2 Weeks) for assessing snoring reduction. 
CPAP - formal appraisal of CPAP for sleep apnoea suspects.
N - Normal (AHI. <5/hr), B - Borderline (AHL 10-15/hr or RDI 5-15/hr), 
P - Possible OS AS (AHI. 15-25/hr), D - Definite (AHI >25/hr).
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Appendix B Assessment by Questionnaire 
The Epworth Sleepiness Scale
Name:______________________
Today’s date:________________
Your sex (male = M; female = F):
How likely are you to doze off or fall asleep in the following situations, in contrast to feeling just 
tired ? This refers to your usual way of life in recent times. Even if you have not done some of 
these things recently try to work out how they would have affected you. Use o f  the following  
scale to choose the most appropriate number for each situation.
0 = would never doze
1 = slight chance of dozing
2 = moderate chance of dozing
3 = high chance of dozing
Situation Chance of dozing
Sitting and reading ---------------------
Watching TV ---------------------
Sitting, inactive in a public place (e.g. a theatre or a meeting)--------------------------- ---------------------
As a passenger in a car for an hour without a break ---------------------
Lying down to rest in the afternoon when circumstances permit ---------------------
Sitting and talking to someone ---------------------
Sitting quietly after a lunch without alcohol ---------------------
In a car, while stopped for a few minutes in traffic----------------------------------------- ---------------------
Bl. The Epworth Sleepiness Scale. Individuals are asked a series of questions 
related to the likelihood of their falling asleep in various circumstances. The 
likelihood is scored from 0-3 in each of 8 situations giving a total possible score 
of 24. A score of 16 or above is considered high.
Your age (years)
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BASIC NORDIC SLEEP QUESTIONNAIRE
QUESTION 1 Do you snore while sleeping (ask other people)?
Response alternatives: never or less than once per month
less than one day per week 
on 1-2 days per week 
on 3-5 days per week 
daily or almost daily
QUESTION 2 How do you snore (ask other people about the quality of
your snoring)?
Response alternatives: I don’t snore
My snoring sounds regular, and it is of low voice 
It sounds regular, but rather loud
It sounds regular, but it is very loud (other people hear me 
in the next room)
I snore very loudly and intermittently (there are silent 
breathing pauses when snoring is not heard and at times 
very loud snorts with gasping)
QUESTION 3 Have you noticed breathing pauses (sleep apnoea) during
sleep (have other people noticed that you have pauses in 
respiration when you sleep)?
Response alternatives: never or less than once per month
less than one day per week 
on 1-2 days per week 
on 3-5 days per week 
daily or almost daily
QUESTION 4 If you snore at least one to two times per week, how many
years have you been snoring (ask other people if you don’t 
know)?
Response: The answer is: “I have been snoring for
about_______years.”
“I was about years old when I started to snore.”
B2. Basic Nordic Sleep Questionnaire. Questionnaire used by the 
Scandinavian Sleep Research Society, Partinen et al (1988).
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Predictors and prevalence of obstructive sleep apnoea 
and snoring.
Height
Weight
Neck circumference,
Arterial oxygen saturation (SaC>2),
Sapirometric values.
Alcohol consumption
Categories 1-4: <10g/day, 10-39g/day, 40-70g/day, >70g/day
Cigarette consumption
Categories 1-4: nil, 1-5/day, 6- 15/day, > 15/day
Nasal stuffiness e.g. hayfever, previous nasal damage or surgery. 
Previous adentonsillectomy.
Use of sedative or hypnotic drugs.
Regular use of other drugs.
Subjects asked about snoring (partner present)
Occupation
B3. Questionnaire used by Stradling and Crosby (1991).
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Questionnaire for Sleep Apnoea and/or Snoring
NAME DATE
1. How long have you been aware of your snoring?
2. Has it caused problems for relatives or friends?
3. Have you been told your breathing stops while asleep?
4. Have you been told you move around a lot while asleep?
5. About how many times per night do you wake up?
6. Do you have any difficulty falling asleep at night?
7. How many hours of sleep a night do you get?
8. Do you most often wake up feeling refreshed?
9. Do you often wake up with a headache?
10. Will a small amount of alcohol give you a headache?
11. Do you feel sleepy during the day frequently? occasionally? seldom? 
Never?
12. What other doctors have you seen about your snoring or sleep apnoea?
13. Have you had a sleep lab study?
14. Do you have any difficulty breathing through your nose?
15. Have you gained weight recently? About how much?
16. Present body weight? Height? ft. inches
17. What professional advice or treatment have you received about your
snoring or sleep apnoea?________________________ __
Signature Date
(A positive response to questions 3, 4, 9, 10, 11 may have OS AS)
B4. Questionnaire used by George (1993). It was suggested that 
positive response to questions 3, 4, 9, 10, 11 may have OSAS.
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APPENDIX C PATIENT DOCUMENTATION
THE MANAGEMENT OF SNORING AND OBSTRUCTIVE SLEEP APNOEA WITH AN INTRAORAL 
DEVICE
INVESTIGATORS
Mr Donald A. Cameron Glasgow Dental Hospital and School
Dr Mervyn F. Lyons Glasgow Dental Hospital and School
Dr Stephen Banham Glasgow Royal Infirmary
Patient questionnaire for snoring and/or sleep  
apnoea
(Before Appliance)
Title! Dr, Mr, Mrs, Ms, Miss. Delete as appropriate.
NAME: DATE:
Address:
Reference No.
Telephone (Daytime).  Home
Date of Birth: SEX: M. F.
Marital Status:_____________
Occupation:__________________________________________________
Please tick a box, where provided.
A. How long have you been aware of your snoring?______________ Years.
B. How loud do you think you snore? (from what other people tell you).
On the scale below, indicate with a single mark:
Do not snore Extremely
at all loud
C. Has it caused problems for relatives or friends ?_______________________
Cl. Pre-appliance patient questionnaire A1 (Page 1).
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1. How many hours of sleep a night do you get?
2. Do you wake up feeling refreshed?
On the scale below, indicate with a single mark:
Never Always
3. Do you feel sleepy during the day?
On the scale below, indicate with a single mark:
Never Always
4. Present body weight st lbs. Height ft. inches
(office use) BMI______
5. Do you smoke YES NO Cigarettes Cigar Pipe
1-5 per day 6-15 per day more than 15 per day
6. Do you drink alcohol YES NO
Alcohol consumption: In units
A leaflet from the Scottish Council on Alcohol is provided  to assist you.
Average units per week ______
7. How would you rate the quality of your sleep? 
On the scale below, indicate with a single mark:
Awful Excellent
C l (continued). Pre-appliance patient questionnaire A1 (Page 2).
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COMMENTS
Signature of patient 
Date
Thank you for your co-operation
Cl (continued). Pre-appliance patient questionnaire A1 ( Page 3).
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THE MANAGEMENT OF SNORING AND OBSTRUCTIVE SLEEP APNOEA WITH AN INTRAORAL
DEVICE
INVESTIGATORS
Mr Donald A. Cameron Glasgow Dental Hospital and School
Dr Mervyn F. Lyons Glasgow Dental Hospital and School
Dr Stephen W. Banham Glasgow Royal Infirmary
Partner questionnaire for snoring and/or sleep  
apnoea
(Before Appliance)
Patient Name_____________________________ Reference No.
NAME:_______________________________ DATE:
Address:________________________________
Reference No.
Please tick a box, where provided.
A. How long have you been aware of your partner snoring?___________ Years.
B. How loud does your partner snore?
On the scale below, indicate with a single mark:
Does not snore Extremely
at all loud
C. Has your partners snoring caused problems for relatives or friends?
C2. Pre- appliance partner questionnaire B1 (Page 1).
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1. Does your partner wake up feeling refreshed?
On the scale below, indicate with a single mark:
Never
2. Is your partner irritable upon wakening?
On the scale below, indicate with a single mark:
I
Never
3. Does your partner complain of daytime sleepiness?
On the scale below, indicate with a single mark:
1
Never
The following questions relate to your sleep.
4. Is your sleep disrupted by your partners snoring? YES
NO
If yes, on average how many times per night?
5. Do you feel tired upon wakening?
On the scale below, indicate with a single mark:
i 1
Never
6. How would you rate the quality of your sleep?
On the scale below, indicate with a single mark:
1
Always
Always
Always
Always
Awful Excellent
C2 (continued). Pre- appliance partner questionnaire B1 (Page 2).
COMMENTS
Signature of partner Date
Thank you for your co-operation
C2 (continued). Pre- appliance partner questionnaire B1 (Page 3).
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THE MANAGEMENT OF SNORING AND OBSTRUCTIVE SLEEP APNOEA WITH AN INTRAORAL
DEVICE
INVESTIGATORS
Mr Donald A. Cameron Glasgow Dental Hospital and School
Dr Mervyn F. Lyons Glasgow Dental Hospital and School
Dr Stephen W. Banham Glasgow Royal Infirmary
Patient questionnaire for snoring and/or sleep  
apnoea
(After appliance) 
Evaluation of Dental Appliance
NAME:________________________________DATE:
Address:________________________________
Reference No.
Please note when answering, th a t questions relate only to the last 4 
weeks.
Please tick a box, where appropriate.
A. How often do you wear the appliance?
1 day per week
2 days per week
3 days per week
4 days per week
B. How comfortable is the appliance to wear?
On the scale below, indicate with a single mark:
Extremely 
uncomfortable
C. Did the appliance make a difference to your snoring?
On the scale below, indicate with a single mark:
None Entirely
at all eliminated snoring
Totally
comfortable
5 days per week
6 days per week
7 days per week
C3. Post-appliance patient questionnaire A2 (Page 1).
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D. How satisfied are you with the appliance?
On the scale below, indicate with a single mark:
Extremely Totally
dissatisfied satisfied
E. Were there any side effects from wearing the appliance:
C3 (continued). Post-appliance partner questionnaire A2 (Page 2).
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1. How many hours of sleep a night do you get?
2. Do you now wake up feeling refreshed?
On the scale below, indicate with a single mark:
Never Always
3. Do you now feel sleepy during the day?
On the scale below, indicate with a single mark:
Never Always
4. Present body weight st lbs Height ft. inches
(office use) BMI_________
5. Do you smoke? YES NO Cigarettes Cigar Pipe
1-4 per day 6-15 per day more than 15 per day
6. Do you drink alcohol: YES NO
Alcohol consumption: In units
A leaflet from  the Scottish Council on Alcohol is provided to assist you.
Average units per week________
7. How would you rate the quality of your sleep now?
On the scale below, indicate with a single mark:
Awful Excellent
C3 (continued). Post-appliance patient questionnaire A2 (Page 3).
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COMMENTS
Signature of patient Date
Thank you for your co-operation
C3 (continued). Post-appliance patient questionnaire A2 (Page 4).
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THE MANAGEMENT OF SNORING AND OBSTRUCTIVE SLEEP APNOEA WITH AN INTRAORAL
DEVICE
INVESTIGATORS
Mr Donald A. Cameron Glasgow Dental Hospital and School
Dr Mervyn F. Lyons Glasgow Dental Hospital and School
Dr Stephen W. Banham Glasgow Royal Infirmary
Partner questionnaire for snoring and/or sleep  
apnoea
(After appliance)
Patient Name______________________________Reference No.
Treatment date: weeks
NAME: DATE:
Address:
Reference No.
Please note when answering, that questions relate only to the last 4 
weeks.
Please tick a box, where provided.
A. Have you noticed a difference in your partner’s snoring now with the 
appliance?
On the scale below, indicate with a single mark:
None Entirely
at all eliminated snoring
B. How loud does your partner snore now?
On the scale below, indicate with a single mark:
Does not Extremely
snore at all loud
C4. Post- appliance partner questionnaire B2 (Page 1).
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1. Does your partner now wake up feeling refreshed?
On the scale below, indicate with a single mark:
Never
2. Is your partner irritable now upon wakening?
On the scale below, indicate with a single mark:
1 1
Never
3. Does your partner now complain of daytime sleepiness?
On the scale below, indicate with a single mark: 
1 1
Never
The following questions relate to your sleep.
4. Is your sleep now disrupted by your partners snoring? YES NO
If yes, on average how many times per night?
5. Do you now feel tired upon wakening?
On the scale below, indicate with a single mark:
Never
6. How would you rate the quality of your sleep now?
On the scale below, indicate with a single mark:
Always
Always
Always
Always
Awful Excellent
C4 (continued). Post- appliance partner questionnaire B2 (Page2).
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COMMENTS
Signature of partner Date
Thank you for your co-operation.
C4 (continued). Post-appliance partner questionnaire B2 (Page 3).
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Questionnaire A1
A. How long have you been snoring? 
appliance?
Years
Questionnaire A2
A. How often do you wear the
1 day, 2 days/week, 3 days/week, 4 days/week 
5 days /week, 6 days/week, 7 days/week
B. How badly do you think you snore? 
to (From what other people tell you) 
Does not snore at all - Extremely loud
B. How comfortable is the appliance 
wear?
Extremely uncomfortable- totally comfortable
C. Has this caused problems for relatives or friends? 
now?
Comment
C. How badly do you think you snore
(from what other people tell you) 
Do not snore at all - Extremely loud
D. How satisfied are you with 
the appliance?
Extremely dissatisfied - Totally satisfied
E. Were there any side effects from
wearing the appliance?
Comment
1. How many hours sleep do you get? 
you
2. Do you wake up feeling refreshed? 
refreshed?
3. Do you feel sleepy during the day? 
day?
4. Present body weight? BM I
Never - Always
Never - Always
1. How many hours sleep a night do 
get?
2. Do you now wake up feeling
3. D you now feel sleepy during the
4. Present body weight? BMI
5. Do you smoke? 5. Do you smoke?
Yes/No - Cigarettes, C igar, Pipe - 1-5,6-15, >15/day
6. Do you drink alcohol? 6. Do you drink alcohol?
Yes/No Units/week
7. How would you rate the quality of your sleep? 7. How would rate the quality of your 
sleep now?
Awful - Excellent
Comments Comments
C5. Summary of Questionnaires A1 and A2 (Patient)
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Questionnaire B1
A. How long have you been aware o f your 
partner’s snoring?
Years
B. How loud does your partner snore? 
now?
Does not snore at all
Questionnaire B2
A. Have you noticed a difference in your 
partner’s snoring now with the appliance ?
None at all - Entirely eliminated snoring
B. How loud does your partner snore 
- Extremely loud
C. Has your partner’s snoring caused problems 
for relatives or friend?
Comments
1. Does your partner wake up feeling refreshed? 1. Does your partner now wake up
feeling refreshed?
Never - Always
2. Is your partner irritable upon wakening? 2. Is your partner irritable now upon
wakening ?
Never - Always
3. Does your partner complain of daytime sleepiness? 3. Does your partner now complain of
daytime sleepiness?
Never - Always
4. Is your sleep disturbed by your partners snoring? 4. Is your sleep now disturbed by your
partner’s snoring?
Yes/No If yes, times /night
5. Do you feel tired upon wakening? 5. Do you now feel tired upon
wakening?
Never - Always
6. How would you rate the quality o f your sleep? 6. How would you rate the quality of
your sleep now?
Awful - Excellent
Comments Comments
C6. Summary of questionnaires B1 and B2 (Partner)
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THE MANAGEMENT OF SNORING AND OBSTRUCTIVE SLEEP APNOEA 
W ITH  AN INTRAORAL DEVICE
INVESTIGATORS
LOCATION
Unit of Prosthodontics, Glasgow Dental Hospital and School 
DATE
27 October 1996
PRINCIPAL INVESTIGATOR - Donald A. Cameron
SUPERVISOR - Mervyn F. Lyons 
SUPERVISOR - Stephen W. Banham
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INTRODUCTION
It has been shown that dental devices can be of value in the treatment of snoring and obstructive 
sleep apnoea. Snoring may affect 20% of the adult population and is a primary symptom of 
Obstructive Sleep Apnoea Syndrome, a condition where the airway is narrowed or blocked, 
obstructing breathing while sleeping. During the apnoeic episodes, oxygen levels in the blood 
drop and the subject resumes breathing with gasps or snorts. This pattern can be repeated many 
times during the night. This leads to poor sleep, snoring, daytime sleepiness, impaired cognitive 
function and an increased risk of cardiovascular disease. Treatments for this condition includes 
the use of a nasal mask (Nasal Continuous Positive Airway Pressure). This is worn while the 
subject is asleep and acts as a pneumatic splint to blow air and keeps the airway open. Surgery 
has also been used to remove excess tissues in the throat to prevent obstruction and reduce the 
vibration o f tissues.
Unfortunately CPAP is a very obtrusive method of treatment, and dental devices are much less 
obtrusive. It is thought that dental devices may have a useful role to play in patients who are 
unsuitable for surgery and would therefore be committed to long term CPAP. We have 
developed a polyvinyl acetate-polyethylene bimaxillary splint and wish to investigate the 
effectiveness of this device in a carefully designed and well-documented trial.
AIMS
To obtain reliable data on the efficacy of the bimaxillary splint in various categories of patients, 
and to further develop this device as may be indicated by experience.
METHODS
A large group (in excess o f 20) of patients will be referred from Glasgow Royal Infirmary with 
symptoms o f Snoring and Obstructive Sleep Apnoea. The patients will be clinically evaluated, 
including sleep studies, at Glasgow Royal Infirmary before referral. The subjects in the study will 
be patients with mild to moderate sleep apnoea. The patients will be randomly allocated into 
two groups with one group acting as a control. At the Dental Hospital, the A group will be 
asked to complete a questionnaire. A jaw  registration and impressions will be taken and a 
bimaxillary splint will then be made. The A group will receive their appliance that day. They 
will wear the appliance for four weeks after which time they will return to the Dental Hospital to 
complete a second questionnaire. The B group patients will also be asked to complete the 
questionnaire, a jaw  registration and impressions will be taken. The B group will be given their 
appliance after a 4 week period when they will be asked to complete they same questionnaire as 
before. The B group will wear the appliance for four weeks and complete the second 
questionnaire. Patients will be asked to attend the Dental Hospital with their partners who will 
also complete questionnaires before the treatment and after the four-week period. An evaluation 
of the appliance will be made after six months, with an evaluation also at Glasgow Royal 
Infirmary.
EVALUATION
A pre-and post-appliance polysomnography investigation will be conducted on each patient at the 
Glasgow royal Infirmary and questionnaires for patient and partner will be completed at the 
Glasgow Dental Hospital.
INFORMATION ON SUBJECTS AND ANALYSIS OF DATA
Information on subjects will be recorded on paper and kept confidential. Analysis of recordings 
and data will be done on a PC, and code numbers will identify subjects only.
Cl. (continued). Ethics Committee Application - Page 2
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THE MANAGEMENT OF SNORING AND OBSTRUCTIVE SLEEP 
APNOEA WITH AN INTRAORAL DEVICE
INVESTIGATORS
INFORMATION SHEET FOR VOLUNTEERS
The results of your assessment have confirmed the presence of a sleep breathing 
disorder. The spectrum ranges from disruptive snoring through to obstructive 
sleep apnoea syndrome. Treatments for these conditions range from simple 
dietary measures through to specialised ENT surgical procedures. The range of 
treatments appropriate to your own condition will have been discussed with Dr 
Banham.
Currently all forms of treatment have some limitation and a new form of 
treatment has been developed in association with the Glasgow Dental School. 
This is a new appliance consisting of an individually measured and constructed 
mouthguard which when placed in the mouth slightly alters the shape of the jaw 
and increases the air channel at the back of the throat. Various versions of this 
device have been studied principally in North America, and show encouraging 
results. We would like you to help in assessing this locally developed appliance. 
A half day session at the Dental Hospital is required for the necessary 
measurements and to mould the plastic material to your own individualised 
“gumshield”. The only reported side-effect of this approach is of some initial 
jaw discomfort.
At the Dental Hospital you will be asked to fill in a questionnaire at the start of 
your treatment and at a follow-up appointment after 4 weeks. There will be a 
further recall appointment 6 months from the treatment.
The sequence of the treatment will be:
1. Evaluation and sleep test at Glasgow Royal Infirmary.
2. Referral to Glasgow Dental Hospital and School where impressions will be 
taken for the construction of the appliance if you have sufficient teeth. There will 
be a questionnaire for you at this appointment. There will be an appointment for 
the patient at 4 weeks after delivery of the appliance when you will be asked to 
fill in a second questionnaire. There are also questionnaires at these stages for 
your partner. It would greatly assist the study if your partner accompanied you 
to fill in their questionnaire.
3. An evaluation and sleep test at Glasgow Royal Infirmary at 6 months from 
the treatment date.
Mr Donald A. Cameron 
Dr Mervyn F. Lyons 
Dr Stephen W. Banham
Glasgow Dental Hospital and School 
Glasgow Dental Hospital and School 
Glasgow Royal Infirmary
C8. Patient information sheet - Page 1
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Patients will be required to sign a consent form at the beginning of treatment.
Your general practitioner will be informed of participation in the study. 
Information will be recorded on paper and kept confidential. Analysis of 
recordings and data will be done on a computer, and code numbers will identify 
subjects only.
No information will be disclosed without the permission of the patient to any 
other party in a manner that would reveal their identity.
Appliance Maintenance
When not in use the appliance should be cleaned with warm water, soap and a 
soft brush. It can be stored in water or a mouthwash solution.
Immersion in hot water can result in distortion of the appliance and should be 
avoided.
If you have any questions or comments regarding the appliance, please do not 
hesitate to contact Mr Cameron (telephone: 0141 211 9622) or Dr Lyons 
(telephone : 0141 211 9625). Outwith office hours Mr Cameron can be 
contacted on (01698 428162).
C8. (continued). Patient information sheet - Page 2
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CONSENT FORM:
THE MANAGEMENT OF SNORING AND OBSTRUCTIVE SLEEP 
APNOEA WITH AN INTRAORAL DEVICE
I,_______________________ of___________________________
freely and voluntarily agree to participate in the clinical research study named 
above.
The nature and purpose of the study has been explained to me by___________
I have had the opportunity to ask questions and I fully understand what is 
proposed.
I recognise that I am free to withdraw my consent at any time without prejudice 
to me.
I have been assured that the information obtained from me will not be disclosed 
without my permission to any other party in a manner which will reveal my 
identity.
Volunteers signature
DATE:______________________
I confirm that I have explained the nature and purpose of the clinical research 
study and the procedure in respect of which consent has been given by the above 
named.
D. A. Cameron M. F. Lyons
DATE:
CIO. Volunteer consent form.
159
UNIVERSITY
GLASGOW
Telephone for appointments: 0141 211 9634 
(Please ask for Dr Lyons’ nurse)
Date:
Dear
You have been referred to this Unit by Dr Banham, Glasgow Royal Infirmary, for 
the fitting of a device to help reduce your snoring. This device is a new design 
and so we are recording detailos of your snoring problem very carefully by 
questionnaire in order to measure the effectiveness of the device. It is very 
important that your spouse/partner comes with you for your first appointment so 
that we can obtain a complete picture of your problem, and so your co-operation 
in this regard would be greatly appreciated. If this is not convenient on the date 
we have sent you, would you please telephone for an alternative appointment.
Would you please note that this device requires natural teeth to hold it in place, 
so if you wear full dentures we cannot help you. Please telephone us to clarify if 
you are in doubt.
Yours sincerely.
Dr M.F.Lyons
C ll. Letter sent with initial appointment from the Dental Hospital.
G LA SG O W  DENTAL HOSPITAL A N D  SC H O O L
------------------------------------- NHS TRUST------------ -------------------------
378 SAUCHIEHALL STREET, GLASGOW G2 3JZ 
TELEPHONE: 0141-211 9600 FAX: 0141-211 9800
HAC/MMCC/03 
22 July 1996
Mr Donald Cameron 
Dental Instructor 
Teaching Laboratory 
Floor 2
Dear Mr Cameron
Area Dental Ethics Committee
Protocol: The management of snoring and obstructive sleep apnoea 
with an intra-oral device.
I write to inform you that your protocol for a clinical research project 
has now been approved b y  the Area Dental Ethics Committee subject 
to
a) The protocol should state th a t. subjects will have mild or 
moderate sleep apnoea or snoring which has not responded to 
standard treatment.
b) The patient questionnaire should be submitted.
c) The investigator will comply with the requirements of the Data 
Protection Act.
d) General practitioners will be informed of patients in the stu d y .
e) The Information Sheet should have a contact home telephone 
number.
f) There should also be an information sheet for partners.
g) The protocol and information sheet should make clear the 
sequence of events in the investigation, ie sleep test, 
construction of appliance, questionnaires at 1, 4, 12 weeks and 6 
months, sleep test .
The Committee would be grateful if you would inform them of the 
results i of your project and any ethical problems encountered when 
the project is complete.
Yours sfecerely
ow
\ Ethics Committee
H A C
Area D
